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iABSTRACT
Selected Reaction Monitoring (SRM), is a form of mass spectrometry that
guarantees high throughput and also a high level of selectivity and specificity.
Performing SRM experiments requires the development of assays to aid in
peptide identification. This is a time consuming and expensive process thus
biological researchers have come up with bioinformatics solutions for the design
of SRM assay. The accuracy of these bioinformatics methods is quite high and
the next step is to optimise the process by tackling the interference issue. As
various analytes may have the same signals within an SRM experiment and
thus interfere with each other’s signals, different solutions are being derived to
tackle the issue.
This thesis describes the development of a SRM transition database to store
peptide and transition data, software to populate the database and also
software to retrieve the data from the database. Finally the database is tested
with the MRMaid transitions for the human proteome which were mined from
the PRIDE database and the results analysed to investigate the transition
interference issue.
The database currently contains data for 20220 proteins and approximately
870,000 tryptic peptides from the human proteome.
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11 Introduction
1.1 Proteomics
Following the completion of genome sequencing efforts for several prokaryotic
and eukaryotic organisms, (Aebersold and Cravatt, 2002), biological
researchers began to tackle the task of interpreting the results of the translation
of these sequences into proteins. In response to this, a new field has emerged.
This field following on from the fields of genomics and transcriptomics is known
as proteomics (Yates et al., 2009). According to (Ray et al., 2012) proteomics is
the systematic study of proteins encoded by a genome for their expression,
localization, interaction and post-translational modifications. The term proteome
was first introduced in the mid-1990s and it was used to describe the functional
complement of a genome (Zybailov et al., 2005) and can be defined as the
complete set of proteins, expressed in the lifetime of a cell including those that
have been post-translationally modified, (Forner et al., 2007).
The idea is that proteomics will enable researchers develop new technologies
that will bring forth the discovery of new therapies and medical advancements
and thus further increase our understanding of cellular biology. In order for
these goals to be met there are several technical challenges that must be
overcome. Challenges that have in the past limited efforts in the quantification
and identification of proteins from highly complex samples (Aebersold and
Cravatt, 2002).
At the beginning of the proteomics era more than 10 years ago (Messana et al.,
2013), the main method of studying proteins was 2D gel electrophoresis. The
advancement in proteomics from that has led to the utilization of many different
methods coupled together to form an efficient system whose main goal is to
solve the many different issues concerned with the study of proteins. Examples
of such systems, include the mass spectrometry technique in conjunction with
high-throughput separation techniques such as liquid chromatography (LC).
Though the methods with which to study proteins and retrieve valuable
information about their nature are not as advanced as those used to study
2genes, much progress has been made in their development. These methods
can be divided into two types, qualitative and quantitative proteomics. They
have become more complex and advanced with time and this is fuelled by the
desire to describe the proteins and understand their precise functions. They
have developed from the more basic gel-based methods such as gel
electrophoresis to currently high – throughput methods such as mass
spectrometry. Mass spectrometry allows the quantitative and qualitative study
of proteins in far greater measures than previously possible.
The primary goal of qualitative proteomics is to define the complete set of
proteins present in a sample including post –translational modifications
(Messana et al., 2013) without particular concern for quantity. Though this in
itself is significant, there is the chance of suppression of low abundance
proteins within a sample thus preventing them from being detected. This causes
difficulties when specific proteins such as biomarkers, within a sample may be
of great importance but due to concentration levels they cannot be measured
adequately. Qualitative studies focused on protein identification relying on
shotgun strategies are now being complemented with large scale quantitative
experiments, (Kiyonami et al., 2011). This has come about as a result of the
demand for identification of the proteins supplemented with the need to acquire
enough information about their quantities in order to make modelling of these
proteins in systems biology possible.
Quantitative proteomics on the other hand is defined by (Karp and Lilley.,
2007), as the comparison of distinct proteomes which enables the identification
of protein species. These protein species are identified by the changes in
expression or post-translational state in response to a given stimulus. General
approaches of quantitative proteomics can be further divided into relative and
absolute quantitation.
1.2 Methods Used in Proteomics Analysis
A proteomic analysis include the top down methods where the proteins are
analysed intact or the bottom up methods proteins are enzymatically digested
into peptides according to (Yates et al., 2009). A detailed understanding of
3protein digestion is very important where quantitative proteomics is concerned.
This is because the efficiency of digestion is proportional to results which are
easily reproduced and enables a standardization of empirical practice (Switzar
et al., 2013).
Protein digestion can be performed with the use of enzymes or by chemical
means. It is an important process in proteomics as a vast majority of the
proteomics experiments rely on the digestion of protein into peptides (Switzar et
al., 2013). The analysis of peptides are preferred to protein in many proteomic
experiments due to the factors such as the length of the polypeptide, lower
molecular mass, charge states and more efficient separation by liquid
chromatography which result in an increase in sensitivity in experiments. The
most common method for digesting proteins is by the use of proteolytic
enzymes. There are many proteases available for this purpose (Switzar et al.,
2013) and they differ in their modes of action on proteins which means that a
researcher can tailor his experiment through the use of a specific enzyme. The
most widely used enzyme is trypsin due to its predictable action and the size of
peptides it produces after digestion. The peptides produced by trypsin are ideal
for MS and thus it has become the gold standard in MS experiments.
Among the first methods used to study proteins were gel – based techniques
which were as a result of the emergent understanding of chemistry at that time
period. These techniques were mainly based around the electrochemical
properties of the proteins and their behaviour in chemical matrices.
They were focused not only on the visual observance of the proteins in
mediums but also on their electrochemical properties. Later methods take into
account these electrochemical properties but due to larger amounts of
information produced use more sophisticated methods to observe and measure
the actions of the proteins. This need to analyse these experimental results
resulted in biologists using computational tools to expedite the process.
Nowadays it is possible for proteins to not only be measured, observed and
analysed by complicated tools, but also for extrapolations such as the prediction
of the structure of certain proteins to be made from sequence alone. This is the
4area of bioinformatics and computational biology where scientists now have the
ability to use the power of computing to create solutions to problems in biology
by simulating biological environments and conditions.
There are several proteomic tools available and they fall under several
proteomic methods such as separation methods, MS methods and relative and
absolute quantification methods. Tools used for separation methods include
capillary and gel electrophoresis, micro channel, protein chips and Liquid
Chromatography (LC) and High-Performance Liquid Chromatography (HPLC)
(Palagi et al, 2006). MS methods include Electrospray ionisation (ESI), Matrix
assisted laser desorption ionisation (MALDI) as ionisation sources, Triple
quadrupole (QQQ) and Fourier Transform-Ion Cyclotron resonance FT-ICR
Shotgun approach.
Relative quantitative methods include label-free and labelled methods. The
labelled methods consist of metabolic labelling such as the Stable isotope
labelling by amino acids in cell culture (SILAC) method. Enzymatic labelling
such as 18O- labelling and chemical labelling methods such as Isobaric tags for
relative and absolute quantification (iTRAQ), tandem mass tags (TMT),
difference gel electrophoresis (DIGE) and isotope-coded affinity tags (ICAT).
The label-free approach includes methods such as spectral counting, peak
intensity and densitometry where quantification involves comparing the peak
intensity of the same peptide or the spectral count of the same protein (Zhu et
al., 2010).
Absolute quantification methods include methods such as Absolute
Quantification peptides (AQUA) (Gerber et al., 2003) which is a method that
allows for the absolute quantification of proteins and translationally modified
proteins via a two stage process. The first stage involves choosing an internal
standard which is a stable isotope incorporated into a synthetic peptide. The
second stage involves the use of the internal standard, for absolute
quantification. As an absolute amount of the AQUA peptide is added to the
sample, the absolute quantification can then be calculated by the comparison of
the abundance of the AQUA internal peptide against that of the peptide being
5measured (Gerber et al., 2003). The Quantification Concatamers (QconCAT)
method (Rivers et al., 2007), Is a method which involves concatenating
proteolytic peptides chosen from several proteins to be quantified. The
concatenated peptides are then assembled into an artificial protein. An artificial
QconCAT gene is then designed (Brun et al., 2007) which encodes this
concatamer. The QconCAT gene is inserted into a high level expression vector
which is then expressed in Escherichia coli (Benyon et al., 2005). The bacteria
is grown in a growth medium that contains heavy amino acids. The purified
QconCAT protein is digested with the sample to be studied and the mixture of
QconCAT peptides and peptides of the protein to be quantified are then
analysed (Holman et al., 2012). Protein Standard Absolute Quantification
(PSAQ) (Brun et al., 2007) is a method that ‘uses in vitro synthesized isotope
labelled proteins as standards for absolute quantification’. According to (Holman
et al., 2012) PSAQ proteins are added to the sample pre-digestion to facilitate
quantification. The PSAQ protein standards used are a very close biochemical
match to the target proteins and thus can be directly added into the samples to
be analysed (Brun et al., 2007).
Choosing the right separation methods is often the first step in designing the
proteomic application. The major separation methods widely used in proteomics
are gel based and gel free. (Yates et al., 2009).
1.2.1 Separation
1.2.1.1 2D SDS PAGE
Sodium dodecyl sulphate poly acrylamide electrophoresis (SDS – PAGE), is a
technique whereby proteins are separated in gel electrophoresis according to
their charge state and/or size. When Sodium Dodecyl Sulphate (SDS) binds to
proteins it makes the protein molecules linear and imparts a negative charge on
it. 2 Dimensional SDS PAGE is a valuable tool in proteomics and its use
enables the separation of thousands of proteins. The first dimension is an
isoelectric focusing (IEF) step that is performed that allows the proteins to
migrate on the gel along a neutral pH gradient until they reach a position where
they contain no charge. The next step is then to transfer the IEF strip with the
6proteins on it to a polyacrylamide gel. This is the second dimension as it
employs the molecular mass of the proteins. SDS is bound to the proteins in
order to impart a uniform charge on the proteins. A voltage is applied to the gel
and the negatively charged proteins then migrate across the gel toward the
positive end. The protein’s migration across the gel is dependent on the
molecular mass of the molecules. The smaller proteins move further through the
gel matrix as a result of less resistance encountered within the gel matrix. After
the 2D SDS PAGE is complete the gel is stained using several different kinds of
staining methods. There are dye-based staining methods such as Coomasie
brilliant blue, zinc imidazole staining methods, silver stains such as silver nitrate
and silver ammonia and fluorescent stains such as SYPRO Ruby protein gel
stain from the family of SYPRO dyes (Chevalier, 2010). This results in a two
dimensional map of hundreds or thousands of proteins. Proteins of interest
within the gel can also be excised and used in various other techniques such as
mass spectrometry for further analysis. A disadvantage of 2D SDS PAGE is that
spots on a given 2D gel often contain more than one protein (Zhu et al., 2010).
This may make the quantification of the protein of interest difficult as it may be
unclear which protein is being observed.
1.2.1.2 Liquid Chromatography
Chromatography is a technique that can be used to separate thousands of
compounds. There are two types of chromatography. Gas Chromatography
(GC) and Liquid Chromatography (LC). Liquid Chromatography is one of the
main techniques used in proteomics for proteins and peptides analysis. It
involves passing the protein or peptide in solution through a solid phase usually
a column at high pressure. The interaction of the column with the proteins in the
solution, causes the proteins or peptides to separate along the column. As they
emerge from the end of the column a detector measures the molecules. Liquid
chromatography is often used in conjunction with mass spectrometry LC-MS.
This ensures greater selectivity and specificity.
7Figure 1. Simple diagram to show the process of liquid chromatography. The
sample and a solvent are mixed into a solution and then run through the
fractionation column. The proteins within the column elute at a predictable rate
proportional to their hydrophobicity. The detector identifies the substance as it
passes form the column. http://www.chemguide.co.uk
1.2.2 Mass Spectrometry (MS)
At its simplest a mass spectrometer measures the mass – to – charge ratio
(m/z) of ionised molecules (Forner et al., 2007). (Yates et al., 2009) describe
the method as the most comprehensive and adaptable tool in large – scale -
proteins on a large scale (Kito and Ito, 2008). Mass spectrometers are usually
made up of the ion source and optics, the mass analyser and the data
processing electronics (Yates et al., 2009).
Initially in the proteomics field the main tool of choice was 2D PAGE, the issue
with 2D PAGE is that its resolution that can only analyse the most abundant
proteins in a sample (Kumar and Mann, 2009). A new method was needed to
perform more high through – put proteomics. Mass spectrometry has long been
used in the field of chemistry to identify and quantify molecules. Proteomic
mass spectrometry has experienced rapid growth in the past two decades due
to important developments in experimental methods, instrumentation and data
analysis approaches (Yates et al., 2009). The ability to present proteins or
8peptides in an ionised and gaseous state and the maintenance of the
protein/peptide molecule without any degradation was a previous challenge in
proteomics mass spectrometry. MS also has an ability to provide quantitative
information in proteome analysis.
Two breakthrough techniques which were very important for the ability of the
Mass spectrometer to measure proteins are electrospray ionisation (ESI) and
matrix – assisted laser desorption ionisation (MALDI).
Limitations of biological MS require several different methodologies to be
applied to protein analysis. The approaches include sample preparation,
ionization, data acquisition and data analysis. Their application may differ
depending on how complex the sample is and the purpose of the analysis.
Front-end separation is also necessary to detect the signals of low-abundance
proteins that would otherwise be obscured by a higher abundance signal.
Therefore efficient separation is important to the accuracy and sensitivity of a
mass spectrometric experiment (Yates et al., 2009).
9Figure 2. Shows the mass spectrum of the peptide LLYGGSVTGATCK. The
individual amino acids can be elucidated by measuring the peaks and the
distance between the peaks. The m/z of an amino acid is usually an identifier and
the identification can be validated by comparing with against a library of mass
spectra. www.astbury.leeds .ac.uk/facil/mass.htm
1.2.2.1 Electrospray Ionisation (ESI)
One of the most important developments in peptide based mass spectrometry
was the introduction of ionisation methods that allow for proteins and peptides
to be reliably measured by MS. These methods were ESI and MALDI. The ESI
method produces ions from solution. The peptide ions in solution are forced
through a needle and the solution is evaporated until the peptides get into a
state whereby they repel one another. Once this occurs they are dispersed into
a fine mist and the charged ions are collected to be fed into a mass
spectrometer for further analysis.
1.2.2.2 Matrix – assisted Laser Desorption Ionisation (MALDI)
MALDI is the production of ions from the laser activation of a target analyte
which has been fixed on a solid matrix. The resulting ions are mostly singly
charged. This makes MALDI more suitable for top-down analysis of high-
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molecular weight proteins using pulsed analysis instruments (Yates et al.,
2009). MALDI has also led to the use of other techniques such as surface-
enhanced laser desorption ionization (SELDI) which introduces the concept of
surface affinity to the ionisation of protein and peptide molecules.
1.2.2.3 Mass Analysers
Mass analysers are an important part of each MS instrument because they are
able store ions and separate them based on their mass-to-charge (m/z) ratios.
The most widespread mass analysers are quadrupoles (Q), Ion traps (IT), time
of flight (TOF) and (FT-ICR) analysers (Forner et al., 2007). These mass
analysers can be separated into two major categories: the scanning and ion-
beam mass spectrometers, such as TOF and Q; and the trapping mass
spectrometers such as Ion Trap, Orbitrap and (FT-ICR) (Yocum and
Chinnaiyan, 2009). Mass analysers separate ions based on their m/z resonance
frequency, quadrupoles (Q) use m/z stability, and time-of-flight (TOF) analysers
use flight time (Yates et al., 2009). To achieve maximum performance hybrid
combinations of these analysers have been developed such as the (QQQ), ion
trap/FT-ICR and time of flight-time of flight (TOF-TOF). (Forner et al., 2007).
1.2.2.4 Detectors
Fragment ions that pass through the mass analyser are detected by the
detector. The electromagnetic signal determines the number of ions present at
each m/z value. The result is a mass spectrum or chart with a series of spikes
or peaks, each representing a charged protein fragment from the sample. The
height of each peak represents the amount of that particular protein or fragment
that is present in the sample. The size of the peaks and the distance between
them is the protein pattern or array of the entire sample. Each spectrum
contains enough data points for every protein and protein fragment through
which their molecular weight and intensity values may be used to reflect their
relative abundance within the sample. Detectors may consist of multiple
channel plates detectors, photo-multiplier detectors or electron-multiplier
detectors.
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1.2.2.5 Tandem Mass Spectrometry
Tandem mass spectrometry (MS/MS) has been widely used in proteome
analysis, where a peptide ion to be to be analysed is selectively isolated and
fragmented to obtain an MS/MS spectrum (Kito and Ito, 2008). In tandem MS,
mass analysis can be carried out on intact molecular ions or on fragmented
precursor ions. In most cases full scans produce masses of the proteins or
peptides and fragmentation scans yield the primary sequence information.
(Yates et al., 2009).
The fragmented precursor ions are generally referred to as product ions. The
fragmentation is usually by ion dissociation. The most commonly applied
fragmentation method used for proteome identification and quantification
analysis is Collision-induced dissociation (CID) (Quan and Liu, 2013). There are
other dissociation methods such as Electron-transfer dissociation (ETD),
Electron-capture dissociation (ECD) and Infrared Multi-photon dissociation. In
CID conditions the precursor ion undergoes multiple collisions with collision gas
such as helium or argon. The increased ion energy and impact of the collisions
causes predictable fragmentation. CID generally yields b and y type fragment
ions. Complementary to CID fragmentation, ECD which generates radical
cations or ETD which transfers electrons, (Quan and Liu, 2013) result in the
formation of c and z type fragment ions.
12
Figure 3. Peptide Fragmentation. a, b and y ions are the most common ions
observed in low energy collisions. C ions are observed in high energy collisions.
Sourced from Wikipedia
1.2.3 Data Analysis
The raw data retrieved from the mass spectrometry experiment must be
processed and converted to the final result according to (Jones and Hubbard,
2010). Tandem mass spectrometers can now process several tens of
thousands peptide ions per hour. This process requires the use of advanced
13
algorithms for proper interpretation of the data and also without the cost of too
much computational time. The final result following the conversion can either be
protein or peptide identifications. There are three approaches which have been
developed for analysing mass spectrometric data according to (Forner et al.,
2007). These are the knowledge-based approach, an ab-initio approach and a
sequence-tag methods approach.
The knowledge based approach involves comparing the spectra acquired from
the mass spectrometry experiment with a database of theoretical fragments this
approach is relatively simple and robust. SEQUEST, (Eng et al., 1994) is a
commercial online mass spectrometry data analysis tool, which has been
around for a long time and performs protein and peptide identifications using
knowledge based approach and is a non-probability based model. Another tool
that uses the knowledge based approach is Mascot, (Perkins et al., 1999) which
is another popular tool that has been around for use in proteomics for a while. It
is available as a web tool and a standalone version (Cham Mead et al., 2010).
According to (Forner et al., 2007) it utilises a probability based method of mass
spectrometry data analysis. Other probability based tools for protein/peptide
identification utilising the knowledge based approach include X!TANDEM which
was developed as an alternative to SEQUEST and Mascot and has the
advantage of being able to search for post translationally modified peptides
already observed thus reducing the computational time spent calculating all
possibilities of peptide modifications. OMMSA like X!TANDEM is an open
source tool and freely available where identification is based on the probability
of the match being random.
De Novo sequencing is an ab-initio approach that involves the direct elucidation
of the peptide sequence from the fragment ion spectrum. The de novo method
is a mainly database –independent method. Originally this method was carried
out manually but now software tools such as the PEAKS software which is one
of the first and most widely used algorithms, are used to assist in the process.
An advantage of the de novo sequencing method is that it does not require prior
14
knowledge of sequence. De novo sequencing is mainly used in situations
whereby species with limited genome information available are being studied.
The approaches that involve the sequence-tag methods are usually hybrid in
nature and can combine database searching with de novo sequencing. Short
sequence tags from MS/MS spectra are used in a protein database search
together with other information. The search allows for one or more mismatches
between acquired spectra and those in the database. By limiting the search
space to those only containing the sequence tag extracted from the spectrum,
the search time is significantly reduced. This approach is useful for identifying
peptides with post-translational modifications or unknown sequence variations
according to (Forner et al., 2007).
These methods generally utilise the spectra generated by the mass
spectrometry experiments to measure peptide sequence and quantity.
According to (Lai et al., 2013) information which may be obtained from the
spectra include, peptide peak intensity derived from the height or area of a
peak, the peptide precursor ion peak height and the peak height of product ions.
This information can then be used to quantify peptides through methods such
as spectral counting and peptide peak intensity measurement (Wasinger et al.,
2013). This quantification based on peak areas or heights of peptide ions must
take into account several factors such as chemical modifications of the peptide
ions, post translational modifications, uniqueness of the peptide and complete
digestion. Complete digestion is important as every protein within the sample
must be digestible by the enzyme used. This allows shotgun techniques such
as MS to be able to detect every protein present as the proteins produce
peptides that can be detected in terms of size and sensitivity (Elliott et al.,
2009). Though the peak height or the peak area can both be used to measure
peptide quantity, there are advantages of using either one. Using the peak
height to measure quantity is of advantage when the width of the peak does not
vary between samples and there is a strong signal with minimal noise (Zhang et
al., 2010). On the other hand it is preferable to use the peak area when there is
a lot more noise as more information is derived from more data points.
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Interference from other peaks becomes a problem when peak area is used to
measure quantity as a result of the larger area in the m/z and retention time
space used according to (Zhang et al., 2010). This issue of interference is very
important in mass spectrometry based data generation.
This may help the researcher choose to use either peak area or peak height to
measure quantity when designing their own experiment.
1.2.4 Bioinformatics Tools in Proteomics
(Kumar and Mann, 2009) define bioinformatics as a means for functional
analysis and data mining of data sets leading to biologically interpretable results
and insights. Following on from that, the current tools used in proteomics have
generated a very large amount of data. The data poses a lot of challenges for
scientists trying to understand them. The field of bioinformatics is well practiced
in the manipulation of biological data from experience in genomics.
Bioinformatics has evolved to deal with a multitude of different data types and
should now be well – equipped to aid proteomics (Kumar and Mann, 2009). The
number of protein and proteome databases being developed is increasing at a
rapid rate. There is an abundance of information about specific proteins which
can be found in databases that store protein sequences. One such database is
Swiss-Prot. Swiss-Prot is a database that provides access to protein sequences
and to information such as descriptions of a protein's function, its domain
structure, and post-translational modifications and links to other databases.
Peptide identification via Peptide Mass Fingerprinting (PMF) involves the
comparison of experimental peaks from mass spectrometry with theoretically
digested proteins to elucidate the peptide sequence. This uses a number of
algorithms to try and find the most accurate match of the experimental spectra
to theoretical spectra within databases. There are many computer programs
and databases which have been built to help analyse MS data for the
identification of proteins. One of the most widely used tools for PMF is Mascot
which utilises the MOWSE algorithm to provide a score for the most adequate
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match. There are a number of these databases which provide a repository of
MS spectra.
1.3 Selected Reaction Monitoring
There has been a recent trend in proteomics toward the development and
application of technologies for the targeted analysis of proteins within complex
mixtures (Prakash et al., 2009). One such technique is called Selected Reaction
Monitoring (SRM). Selected reaction monitoring (SRM) is a non – scanning,
targeted mass spectrometry technique that can be used to accurately quantify
proteins in complex biological mixtures, (Chang et al., 2012); (Cham Mead et
al., 2010). SRM can be used to overcome the limitations of shotgun – MS/MS
(Holman et al., 2012). While its application is relatively new in proteomics, it is a
method that has been used extensively in the toxicology and pharmacokinetics
disciplines to determine and analyse small molecules for decades (Yocum and
Chinnaiyan, 2009); (Abbatiello et al., 2010). It is only within the last few years
that it has been applied to proteomic research and then mainly to quantitative
proteomics. SRM exploits the capabilities of tandem quadrupole spectrometers
also called triple (QQQ) MS for quantitative analysis (Lange et al., 2008). In
SRM, the first (Q1) and third quadrupoles (Q3) are mass analysers which are
used as filters to monitor selected precursor ion and fragment ions. The first
quadrupole monitors and filters the precursor ion, which in a quantitative
proteomics experiment is the mass – to – charge (m/z) value of an ionised
peptide of interest (Holman et al., 2012). The precursor ion that is selected is
introduced into the second quadrupole (Q2) which serves as a collision cell and
is useful in increasing selectivity. Collision induced dissociation (CID) occurs
within the second quadrupole and the precursor ion is fragmented to produce
product ions. The product or fragment ions are then introduced into the third
quadrupole which detects a preselected fragment ion by is m/z value. See
figure 4 for a workflow of the SRM experiment.
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Figure 4. Workflow of a typical SRM experiment the precursor ion is selected in
the first mass analyser (Q1) then in the collision cell (Q2) the collision energy is
optimized to produce the desired fragment ions. The third mass analyser (Q3) is
set to selects the only fragment ion of interest. http://www.mrmproteomics.com
The SRM technique is a very good candidate for hypothesis driven proteomics,
due to its specificity and sensitivity/ high selectivity of the SRM technique as
well as its multiplexing ability make it a very good candidate for hypothesis
driven proteomics (Chandramouli and Qian, 2009). The detection of biomarkers
can be of utmost importance in medicine. Therefore analytical methods suitable
for accurate research need to be as robust as possible. Selectivity is crucial in
such methods (Sauvage et al., 2008). The SRM technique is equipped to
significantly reduce interferences, thereby allowing a dramatic increase in
selectivity, a very low baseline, very good limits of quantitation and a very good
linearity (Hunter, 2010). The specifically selected and predefined mass – over –
charge (m/z) values of the precursor ion against the fragment ion is known as a
transition. The ionisation efficiency of the parent ion (Q1 transmission), the
fragmentation efficiency of the parent ion and subsequently the intensity of
fragment ion (Q3 transmission) are very important in achieving successful MRM
transitions (Yocum and Chinnaiyan, 2009).
In an SRM experiment several of such transitions are observed over time,
yielding a set of chromatographic traces with the retention time and signal
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intensity for a specific transition as coordinates (Lange et al., 2008). Using the
selectivity of multiple stages of mass selection of a tandem mass spectrometer,
these targeted SRM assays are the mass spectrometry equivalent of a western
blot. (Prakash et al., 2009).
In comparison to discovery centred methods, methods which are SRM based
and use the triple quadrupole mass spectrometers are known to have a high
specificity and sensitivity within a complex mixture and therefore can be
performed in a fraction of the instrument time. (Prakash et al., 2009).
A multiplexed approach can be taken whereby LC-SRM peptide – based assays
can be used for quantifying panels of proteins. This involves measuring multiple
SRM transitions within the same experiment and there is an assumption that the
individual SRM do not interfere with each other within the assay (Mead et al.,
2009). Due to the multiplexed nature of this assay it is usually referred to as
Multiple reaction Monitoring (MRM) and centres on balancing productivity
against sensitivity. Although the SRM term is widely used most people prefer to
represent the method as MRM.
The MRM analysis of numerous peptides enables detection of the different
proteins in a single sample, as opposed to reproductions of the same proteins
and this set of assays could be further expanded to include other endogenous
proteins of interest. (Remily-Wood et al., 2011). The terms SRM/MRM can also
be used to describe experiments that are conducted in instruments other than
triple quadrupole MS (Lange et al., 2008).
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Figure 5. A SRM design workflow. The experiment starts with the selection of a
target protein. This can be based on the focus of the study (biological or
clinical), experiments or from scientific literature. Following this step is the
selection of target peptides (unique, proteotypic). Then for each peptide the most
optimal transitions are selected and then validated. Other assay parameters are
also optimized. These assays are then ready for application in proteomics
experiments to quantify or detect proteins.
Selection of
target protein
Selection of
target peptides
Selection of
transitions
Transition
validation
Optimization of
transitions
Optimization
of other assay
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1.3.1 SRM assay design
The development of an SRM assay for an individual protein is not an easy and
straight forward process. According to (Mead et al., 2009) the critical part of
performing SRM is designing suitable transitions to monitor the peptide and by
extension, the protein of interest. To achieve this goal, there are certain
conditions to be met in order to conduct a SRM experiment.
First a protein of interest selected as a target for quantification is
cleaved/digested into peptides. Then out of all the peptides relating to the
protein of interest a peptide that shows uniqueness for the protein is chosen.
Peptides such as these are termed proteotypic peptides. Then the right
transitions have to be chosen and these transitions are a derivation of fragment
ions specific to the peptide (precursor) ion. The sensitivity of SRM experiments
is highly dependent on these transitions. Though this allows for very good
quantification results the price to pay is in the amount of time required to pick
and choose the right transitions. Following this the transitions derived have to
be confirmed for the identification of the peptide of interest. After these
conditions have been fulfilled other factors such as the collision energy within
the collision cell and the retention time, have to be taken into account. Choosing
the right parameters will help to improve the sensitivity and signal response.
In designing SRM transitions certain rules apply. For Q1 doubly charged parent
ions are favoured over singly charged ions as the doubly charged parent ions
yield higher quality MS/MS fragmentation and y-ions are mostly preferred to b-
ions, (Prakash et al., 2009) found that when choosing SRM methods a higher
performance can be derived from choosing the most intense y-ions found in the
spectrum of a tryptic peptide compared to the normal experimental approach for
selecting product ions and that these methods can be used as a part of
automated development workflows. They also state that the b2 ion is frequently
one of the largest but least selective product ions in the spectrum. (Prakash et
al., 2009). The Q3 fragment should have a greater m/z than the selected Q1
parent ion and if the sequence contains a proline residue, the high abundance
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y-ion created from fragmentation closest to the N-terminal to the proline is
selected (Yocum and Chinnaiyan, 2009) Higher m/z fragments should also be
chosen over lower m/z fragments as they are more informative (Han and Higgs,
2008), this is due to the fact that there is a lower likelihood of obtaining the
same m/z value from an unrelated combination of amino acid residues when a
higher m/z value is used than when a lower m/z value is used.
(Yocum and Chinnaiyan, 2009) have recommended that in addition to choosing
the most intense transition for quantification, two additional transitions should
also be chosen as this will provide the most selectivity and combined reduced
interference from other peptides.
There are other considerations which are taken into account when designing
SRM peptides. These include the length of the peptide which should be
between 8 – 25 amino acid residues. The presence of multiple aliphatic amino
acids such as Alanine (A), Leucine (L), Isoleucine (I) and Valine (V) as these
factors influence the hydrophobicity of the peptide and may cause synthesis
problems. According to (Deutsch et al., 2012) extreme hydrophobicity (low or
high) will also cause inconsistency in observation by LC-MS methods. Factors
which affect the stability of the peptide should be taken into account such as the
presence of oxidation sensitive residues such as, Cysteine (C), Tryptophan (W)
and Methionine (M). N-Terminal Glutamine (Q) residues should also be avoided
as they are converted to pyroglutamic acid. Genetic variants, modified residues,
peptides also showing the best signal intensity and chromatographic peak
shape for a given parent protein are selected (Anderson and Hunter, 2006).
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1.3.2 Bioinformatics and SRM Design
Figure 6. Screenshot for the MRMaid SRM assay design tool. A protein accession
number of interest is entered and the most optimised transitions are computed
and displayed on this interface. The transitions are also ranked according to
their suitability for use in an SRM experiment.
Many SRM experiments aim at comparing protein abundance across conditions
or time points of interest (Chang et al., 2012). SRM experiments however
require a lot of preparation in the form of selecting appropriate signatures for the
proteins and peptides that are to be targeted (Deutsch et al., 2012). In order to
facilitate this, computational and statistical tools have been developed. These
tools allow for faster and more accurate analysis and also help to increase
throughput. The tools assist in SRM assay development, signal processing and
protein significance analysis (Chang et al., 2012). Currently a lot of the tools
available focus on the assay development side of SRM experiments. A
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challenge of performing these targeted protein analysis is the amount of time
spent preparing methods to measure specific transitions for specific peptides
that are both selective and sensitive (Prakash et al., 2009).
The different software resources developed to assist in the design of SRM
assays have their own specific qualities. Predicting the right transitions from
peptide sequence alone requires absolute knowledge of the behaviour of
peptides in various situations such as the cleavage/digestion products of protein
sequences, fragmentation patterns in a collision cell and the ionisation of the
peptides and products. Though there are certain algorithms that return results
with a high degree of confidence, the data is still not conclusive. Therefore
many of the software tools available have followed the route of generating
transition data from mining spectral libraries (Lam et al., 2007).
Various tools such as PRIDE (Vizcaino et al, 2010), PeptideAtlas (Farrah et al.,
2011) and Global Proteome Machine database (GPMDB) act as such spectral
libraries. They have accelerated proteomics research by facilitating more
efficient cross – analysis of datasets, supporting the creation of protein and
peptide collection of experimental data and supporting the development of
software tools (Farrah et al., 2011). These repositories contain millions of
spectral data for peptides, which is a valuable source of information in the
prediction of useful transitions for SRM experiments. These spectral libraries
highlight the importance of high quality annotated data produced by laboratories
and the benefits of maintaining such data sets in a structured way that can be
shared between research laboratories in the proteomics community (Prakash et
al., 2009).
Though some of these repositories also provide the means to design
transitions, there are other more specialised tools that have been developed for
that sole purpose. These software tools come in two forms; web-based and
standalone. The web-based tools are easily accessed via any web server and
are available to anyone while the standalone tools require downloading and
installing on a local machine. The two different avenues have their advantages
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and disadvantages but the end goal is to design transitions using the most
efficient algorithms that the authors can come up with.
Among the web-based tools is the SRM transition design tool MRMaid (Cham et
al., 2010), (Mead et al., 2009). This software resource was originally designed
with SRM assay design as its main focus. It uses spectra data mined from the
PRIDE database to enhance its calculations and recommend transitions (Fan et
al., 2012). It is able to recommend transitions for multiple proteins and will
return results in a manner that will allow researchers the design SRM assay via
the web interface. A number of properties are used to inform the researcher
about the usefulness of the peptide being studied and the transitions returned.
These properties include the (a) Peptide score which is a score that measures
suitability of the peptide for SRM. (b) Retention time (RT) is the estimated
retention time attributed to the peptide sequence and its movement through a
liquid chromatography set up. This is calculated theoretically using the SSRCalc
algorithm (Krokhin et al., 2004). (c) Product ion which is the ion to monitor and
(d) The PRIDE data which is the number of experiments in which the peptide
has been previously observed. Just by entering the peptide/protein sequence/s
to be queried into the web interface these metrics mentioned above including
others are taken into consideration and a transition table is returned with the
most appropriate suggested. This makes MRMaid a very powerful tool and due
to its ease of access a very convenient resource. The next step for the MRMaid
software resource is use interferent information to enable researchers design
the most optimal assays.
Following on from an example of a web-based software resource an example of
a standalone tool is Skyline (Maclean et al., 2010). This is a very popular tool
amongst proteomic researchers wishing to design SRM assays. It is a tool that
must be downloaded and installed on a local machine and works on windows
platform. Instead of initially using peptide libraries to inform its transition
selection process, Skyline offers the option of theoretically calculating
transitions and also allowing researchers to use their own peptide libraries to
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develop their assays. The option is also there to compare these results with a
public repository of MS/MS spectra and returns a result of the most abundant
transitions. Skyline ranks the transitions according to intensity and together with
that uses a dotproduct function which calculates how similar reference spectra
is to your transition to present the best transition. In addition to the interface
which offers more options due to its architecture the ability of researchers to
keep their data within their control makes it a very attractive tool for many
researchers. Other tools include the Global Proteome Machine Database
(GPMBD) which allows researchers to use information obtained by the GPM
servers to validate MS/MS spectra. It also compares the information within the
server to determine the number of times other people have observed the
peptide. This SRMCollider database developed by (Rost et al., 2012) also
allows for the design of theoretical transitions. It also compares the inputted
transitions to other transitions in a selected proteome. The transitions that
interfere with the input transition are noted and a count of the interferences is
returned.
1.3.3 SRM assays and Interference
The high selectivity associated with SRM is actually achieved at two levels (Yan
et al., 2008) the Q1 and Q3 parts of the triple quadrupole MS. The precursor
ions are first selected at the Q1 mass analyser stage by the mass to charge
ratios and then at the Q3 stage any isobaric components are further resolved by
selecting for the product ions of these precursor ions. The formation of these
product ions occurs by collision-induced fragmentation at the Q2 level within a
collision cell and is highly structure specific (Yan et al., 2008). As a result of this
it is expected that the scenario whereby another component with the same
signals at Q1 and Q3 as that of a transition being monitored will be rare. The
actual experimental evidence suggests otherwise and this can be understood
by the fact that there are over 20,000 proteins in the human genome minus the
post transitional modifications. And when digested into tryptic peptides the
number rises into millions. So the probability of finding peptide species with the
same retention times and precursor and product m/z is quite high. The ability to
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distinguish between correct identifications and false positives is a very important
condition for SRM assays (Yocum and Chinnaiyan, 2009). The SRM method
was originally designed and used to study small molecules. Scientists familiar
with the SRM method are aware of the fact that the identification of analytes by
the detection and monitoring of only a few fragment ions is subject to false-
positive identification and imprecise quantification (Abbatiello et al., 2010). This
makes it necessary to have measures in place to ensure the right results. The
main reasons for this false – positive identification and imprecise quantification
may be credited to problems such as interference and ion suppression by the
constituents of the biological matrix (Abbatiello et al, 2010). Peptides are more
complex and larger than small molecules and analytes which the SRM method
was originally designed to study, they share considerable homology and are
measured in very complex matrices. This complexity results in a lot of peptides
with the same ion signals which makes them hard to tell apart by mass
spectrometry data analysis. The interference experienced in a biological matrix
may be as a result of each fragmentation product of peptide only providing
information about one position in that peptide and this may result in the other
peptides resulting in the same transition as the peptide analyte in question
(Yocum and Chinnaiyan, 2009).
Another potential source of interference is in-source fragmentation of abundant
peptides where the fragment ions rather than the precursors are the source of
interference. This is caused by the primary or secondary fragment of the
precursor having the same or nearly the same mass as the transition of interest.
This can be a significant issue for quantification and depends on the level of
sensitivity to be achieved. It is crucial to select transition ions that maximise
specificity and potentially minimise interferences from co-eluting species that fall
within the mass windows and tolerances of the detector (Yocum and
Chinnaiyan, 2009). So the main idea is to be able to confidently select for the
transitions you want with full knowledge of what to expect if there are any
interfering signals or if the researcher is not too sure about the signal he is
observing.
27
Originally interferences were by manual examination of the raw data. Now for
many of the software tools, interference data is incorporated into the workflows
to aid transition design for example GPMDB has incorporated information on
interfering peptides along with their transition results. Other software tools
choose to use software resources that have been designed specifically for
dealing with interference. These tools have various strategies for coping with
the interference issue. (Rost et al., 2012) have developed the SRMCollider
which uses the idea of Unique Ion Signatures (UIS) to detect and avoid
redundancy in transition design. mProphet (Reiter et al., 2011) uses decoy
transitions to create a probability scoring model that filters out interfering
transitions. AuDIT the algorithm for automated detection of inaccurate and
imprecise transitions developed by (Abbatiello et al., 2010) automatically filters
data sets from SID-MRM-MS assays to identify problematic data to the
researcher. Its main aim is to use reference peptides and technical replicates to
detect transitions with interferences (Reiter et al., 2011). The reason for
awareness of interference is most poignant when there are not enough
transitions to reliably monitor a peptide thus it will be very advantageous to be
aware of all interferences within the vicinity. (Sauvage et al., 2008).
1.4 Aim of the thesis
In complex mixtures, chromatographic signals from isobaric or nearly isobaric
precursor peptides might overlap with the specific precursor signals to be
measured. If the product ion signals and the hydrophobicity of the precursor
also overlap, these isobaric or nearly isobaric peptides might hamper reliable
quantification of the specific signals. Performing an SRM assay with higher
resolution can result in improved selectivity but to the detriment of analytical
throughput. This is due to the fact that a higher resolution is likely to increase
dwell time. As mentioned earlier there have been many tools created to aid in
the design of SRM transitions. The problem is that most of these tools do not
have a means of increasing selectivity by addressing the problem of
interferences and the only way researchers tackle this issue is by painstaking
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and subjective manual examination of the raw data (Yan et al., 2008). With the
increasingly multiplexed nature of the SRM experiments it is obvious that this is
a situation that is redundant in the SRM practice.
The overall aim of the thesis is to produce a database of peptides that may be
observed in human proteomics experiments. This database will then be used
within the MRMaid selected reaction monitoring design tool to indicate peptides
that may interfere with those selected by the user. The detection of these
interfering peptides and to be more specific theoretically interfering transitions
will allow a reasonable resolution to be set without compromising analytical
throughput. Considering the number of peptides available to be observed in the
dataset used (Human Proteome). The database tool can help predict the
presence of interference and help experimentally identify them and to also
refine the conditions for the identification of the investigated peptides with the
SRM techniques (Sauvage et al., 2008). Also finding possible interferences may
lead the researcher to resolve or prevent the issue by improving liquid
chromatography separation sample purification finding as using non-interfering
MRM transitions. The tool can help establish the uniqueness of a transition as
the researcher may be monitoring a more abundant protein instead of their
selected protein.
Is the problem of interference a common occurrence and what the probability is
of encountering theoretically interfering transitions when performing your SRM
experiment.
Objective 1: Create Interferent Database
Data containing information about peptides within a proteome needs to be
retrieved related and analysed. The data is then used to find out information
that about transitions that may produce interfering signals during SRM
experiments. The data from the proteome is to be retrieved from the Swiss-Prot
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database and stored on an in house database built in the MySQL database
server.
Objective 2: Populate the database
The interferent database is to be populated with all the peptide and transition
values derived from the proteome. The means of population is via a perl
program that extracts the necessary transitions and compared them with other
transitions within the proteome. The transitions with similar or close values
within a range are then stored as interferents.
Objective 3: Interrogate the database to query the significance of
interferents
An analysis of the database content is then to be performed to reveal the
importance and occurrence of interferents. Information such as the relationship
between precursor and product m/z tolerances and detectable transitions.
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2 Materials and Methods
2.1 Software Development
2.1.1 Database Design
As described in chapter 1, the tracking of interferences to peptide signals in the
Q1 and Q3 phase of an SRM assay is of importance as using a very high
resolution can affect throughput. Storage of all the protein and peptide
information to use in the validation of this process requires the necessary
storage mechanism that has the flexibility and capability to handle such data.
The system of storage requires the ability to keep track of all the relationships
between the data types. The database should also flexible enough to allow for
changes such as expansion and addition of new fields. The database should
also have referential integrity and data integrity as this ensures the quality of the
data
A relational database is the most useful tool for this project as it facilitates the
storage of information in various ways that can enable the organization of data
in a most efficient manner especially as a storage and retrieval tool. For
example relational databases can be easily adjusted, the data within can be
queried in very sophisticated ways with ease and simplicity and this is made
very possible and easy with the application of the appropriate query utilising the
Structured Query Language (SQL). Also connecting the database information to
a web interface is possible which then makes the information stored accessible
to a wider audience.
The design of the database used for this thesis included the understanding of
the requirements for the database, the nature of the data that being stored,
creating the appropriate database-entity relationship diagram, normalising the
entity-relationship diagram and then generating the necessary SQL script to
construct the database.
As shown in figure 7 the MRMinter is a database consisting of 5 tables:
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Peptide – A table of protein accession numbers, peptide sequences and the
hydrophobicity of the peptide transitions to be monitored. This is the parent
table for the precursor and product tables.
Precursor – A table that contains the precursor mass to charge ratio of the
peptide sequence. It also contains the charge states of the peptide. The three
charge states derived from the perl script are stored within these tables. It is
related to the peptide table in a one to many relationship with the peptide table
as the parent table.
Product – A table that contains the product mass to charge ratio of the
theoretically fragmented peptide sequence. It contains the fragment type and
number typically referred to as the product type and product number. It is
related to the peptide table in a one to many relationship and also with the
peptide table as the parent table.
Transition – A table that holds the theoretical transitions derived from the
joining of the above three tables to yield a unique transition. This table is
created specifically to hold any transitions observed within the MRMaid
database.
Interference – A tables that holds the interfering signals related to the
transitions in the transition table. This table is related to the transitions table in a
one to many relationship and is the child table.
Required data fields for the database are
Protein accession number - This is the identification of the protein in the
proteome. This information is retrieved along with the protein sequence from the
curated database Swiss-Prot.
Peptide sequence – After digestion the peptide sequences are stored in the
database.
Hydrophobicity- The hydrophobicity of the protein and peptide is strongly
linked to the amount of time the peptide takes to pass through the LC column.
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This elution time is commonly called Retention time and is a very important
factor in mass spectrometry as it adds to the specific identification of a peptide.
Precursor m/z – following ionization by ESI and MALDI as described in chapter
1 the ion mass to charge ratio (m/z) of the peptide is stored in the database
singly, doubly and triply charged precursor ions are stored as these are the
most readily observed.
Precursor charge – This field identifies the charge state of the precursor ion to
which it is linked.
Product m/z – following the theoretical fragmentation of the peptide using the
principles for fragmentation in a collision cell the resulting fragment ions of type
b and y are stored in the database.
Product type – The type of fragment or product ion is stored in this field. The
product types can either be b or y ions.
Product number – According to the principles the number of amino acids along
the backbone where the peptide was fragmented is stored as the product
number.
All these fields are then taken and stored in the appropriate tables. The Entity –
Relationship diagram in figure 7 shows the tables and their relationships. This
diagram shows the relationship between the different fields and tables. The
peptide, precursor and product tables are normalised to limit redundancy. Due
to the nature of the data and the parameters needed to obtain a range for the
transitions and interferences for the purpose of obtaining the right query
conditions, the transition and interference tables were denormalised.
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Figure 7. Entity – Relationship diagram for the MRMinter database showing the
Schema of the database.
2.1.2 Population of Database
Using the LAMP platform is the preferred course for bioinformaticians and
biologists as it is open source and hence access to a wealth of information that
can enhance any project due to the information being free. The database
management system used is MySQL. It is an SQL based database system. It is
freely downloaded from the main MySQL website. The MySQL database allows
one to query data between two values. These values can be either decimal or
integer values. The Perl programming language is then used for data input and
to query the database. Though there is a host of perl tools in the public domain
the scripts were generated in house. The information for the proteins were
35
downloaded from the Swiss-Prot database and this ensures richly annotated
and robust data. An organisation of the data is highlighted below.
Perl Scripts – Perl is the scripting language of choice within the bioinformatics
community due to its text manipulation abilities and the fact that it is open
source. The main perl scripts written for this project are Populate_mrminter.pl,
Populate_mrminter_transitions.pl, retrieve_interference.pl and
retrieve_interference2.pl .
Populate_mrminter.pl is the program that populates the MRMinter database
with the peptide, precursor and product information. The raw data is
downloaded from the latest Swiss-Prot release The Perl program then performs
a conversion of the peptide amino acid sequence into a mass to charge ratio
and also calculates the charge and hydrophobicity of the peptide. There are two
ways by which the mass of peptides can be calculated (Jones and Hubbard,
2010), by the average mass or mono-isotopic mass. In this case the mono-
isotopic mass was option was taken as MS identifies amino acids by their
mono-isotopic masses.
Data Source – Peptides are derived from proteins and the proteins used in
populating the MRMinter database were retrieved from the Swiss-Prot
database. The Swiss-Prot database is part of the UniProt database. This
database is maintained up of the Swiss institute of Bioinformatics (SIB), the
European Bioinformatics Institute (EBI) and the Protein Information Resource
(PIR). The UniProt database consists of four different main databases namely
Uniprot knowledgebase (UniProt KB) of which consists of two sections: Swiss-
Prot and Translations of EMBL (TrEMBL), UniMes, UniParc and UniRef. Swiss-
Prot which is the source of the proteome data is a protein sequence database
that is manually annotated, reviewed and provides high quality non-redundant
data. According to UniProt about 98% of the protein sequences available from
them are derived from the translation of coding sequences that have been
submitted to the public nucleic databases.
The complete proteome sets containing the protein sequences can be retrieved
from the UniProt website by searching the taxonomic identifier of your target
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organism, with the keyword “complete proteome and reviewed” in the query
box. This brings up a list of proteins and clicking the orange download button
take the user to a new screen with a list of possible formats with which to
download the information. The formats available are Tab-Delimited, Excel,
FASTA, GFF, Flat text, XML and RDF/XML. The format chosen is the FASTA
format as it is suitable for parsing using the perl programming language.
Otherwise it is also possible to download the complete proteome
programmatically at every UniProt release and on the website is an example of
how to do it using the perl programming language. It is also possible to
download the information directly by FTP as the UniProt FTP server caters for
downloading expanded FASTA sets which contain both the canonical and
manually reviewed isoforms available for the most widely used complete
proteomes. Although the data obtained from Swiss-Prot is of high quality it is
worthy to note that there are protein sequences which contain ambiguous
amino acids.
Peptide sequence digestion – The tryptic digest is performed on the data of
the human proteome obtained from Swiss-Prot in FASTA format. This digestion
is carried out according to the rules of the trypsin enzyme proteolysis (Switzar et
al., 2013), it cuts the sequence after Lysine (K) and Arginine (R) but not before
Proline (P). That is to say it cleaves the protein sequence after each lysine or
arginine unless lysine or arginine is followed by proline. The main reason for the
use of trypsin is that mass spectrometry experiments works more efficiently with
peptides up to 3Kda and trypsin usually produces peptides of this size. Also as
trypsin cuts the peptide sequence on the C-terminal side of arginine and lysine,
it guarantees that the peptides will fragment in a across the whole peptide
backbone in a predictable manner. This is because it has been observed that
when a basic residue such as arginine is present in the middle of the peptide
sequence the fragmentation of the sequence is discontinuous with some bonds
remaining intact.
Sorting the peptides- Post digestion, peptide sequences from 3 to 30 amino
acids long are chosen. The usual maximum length of peptides used in many
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SRM experiments is 25 amino acids. In order to make sure information within
the database was as robust as possible and as also according to (Han and
Higgs, 2008) peptides which contain approximately 7-30 amino acid residues
are generally optimal for MRM analysis. Therefore the maximum peptide length
threshold was increased to 30 amino acids. Within the theoretical protein
sequences submitted to Swiss-Prot are ambiguous amino acids (X B Z J). Any
peptides containing these amino acids are discarded.
Hydrophobicity- The hydrophobicity of the peptide is calculated according to
rules laid out by (Krokhin et al., 2004) in their Sequence-Specific Retention
calculator (SSRcalc) peptide retention prediction algorithm.
The hydrophobicity of the protein and peptide is correlated with the amount of
time the peptide takes to pass through the LC column. This elution time is
commonly called Retention time and is a very important factor in mass
spectrometry as it allows specific identification of a certain peptide to a certain
degree. The calculation for hydrophobicity used in this thesis is derived from
(Krokhin et al., 2004) (SSRcalc). This formula for calculating the hydrophobicity
of an amino acid sequence also takes into account the influence of peptide
length (N) on the hydrophobicity of the peptide (Krokhin et al., 2004) and is
calculated as follows
                         H = KL*(∑Rc + 0.42R1cNt + 0.22R2cNt + 0.05R3cNt) if H < 38
                And  H = KL*(∑Rc + 0.42R1cNt + 0.22R2cNt + 0.05R3cNt)
                       -0.3(KL*(∑Rc + 0.42R1cNt + 0.22R2cNt + 0.05R3cNt) – 38) if H ≥ 38. 
Where H = hydrophobicity, if N < 10, KL = 1-0.027*(10-N); if N > 20, KL = 1-
0.014*(N-20); Otherwise KL = 1, Rc = Retention coefficient and RcNt = a second
set of retention coefficients.
Equation 1
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Precursor m/z – following ionization by ESI and MALDI as described in chapter
1, the ion mass to charge ratio (m/z) of the peptide is stored in the database.
Singly, doubly and triply charged precursor ions are stored as these are the
most readily observed ions. The m/z is calculated by the following formula
݉ /ݖ = ([ܯ + (݊ܺ)])/݊
Equation 2
“M is the molecular mass of the peptide, X is the mass of the cation added to
the molecule and n is the integer representing the number of charges”
(Simpson, 2002).
Precursor charge – This field identifies the charge state of the precursor ion
linked to it.
Product m/z – The peptide amino acid sequence is also broken down into
theoretical fragments according to rules that calculate the fragmentation of a
peptide sequence into b and y ions. As mentioned earlier this fragmentation is
meant to duplicate the process that takes place in a collision cell during collision
induced dissociation. In experimental situations during collision induced
dissociation mostly y ions and low m/z b ions are readily observed. In the
database all the theoretical fragment pieces are stored.
Following the theoretical fragmentation of the peptide using the principles for
fragmentation in a collision cell the resulting fragment ions of type b and y are
stored in the database in the product table. The b ions are the sum of the
residue masses from the first AA on the Amino (NH2) -> Carboxy (COOH)
direction in the peptide sequence to the last AA plus the mass of the hydrogen
ion while the y ions are the sum of the residue masses from the first AA on the
Carboxy (COOH) -> Amino (NH2) direction in the peptide sequence to the last
AA plus the mass of water and a hydrogen ion.
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Other perl scripts are written to extract the necessary information from the
database such as count of interference, various peptide precursor and product
ion combinations to form a transition.
Populate_mrminter_transitions.pl
The purpose of this perl script is to populate the transition and interference
tables of the MRMinter database. The information for which transition to insert
into the transition table is obtained from the MRMaid database. It can also be
obtained from a text file if the information is stored in text format. These
transitions are then run through the MRMinter database to make sure they
match, are within the database and also to obtained the hydrophobicity,
precursor m/z and product m/z values which are used to query the database for
interferences. Once the correct transitions are found they are then inserted into
the transition table and then a query is run to search for the interferences. The
resulting transitions that are flagged are inserted into the interference table as
interferences to the target transition.
It is possible to retrieve information about interfering transitions from the
database without using the transition table. The transition table offers
advantages such as speed as the information does not have to be retrieved
from a join on the peptide, precursor and product table as it has been stored
earlier and updated when necessary.
In future the script can be modified to check the regular Swiss-Prot update via
ftp transfer. The main reason for the design of this system is to assist
researchers in making an informed choice when selecting transitions for their
own SRM assay design. The system is intended to be coupled with the MRMaid
transition design tool the in house MRM transition design tool in order to help
identify any interferences pertaining to those transitions.
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2.1.3 The MRMinter output
Retrieve_interference.pl - This perl script retrieves the interfering transitions
from the transition table. This information can be returned as a .csv file or
directly to a web interface.
Retrieve_interference2.pl - This perl script returns a count of the number of
interferences and is suitable if that is the only information required. It can also
be returned as a .csv file or directly to a web interface.
The results generated can be printed directly onto screen or exported or
converted to CSV format to enable integration to other analysis programs.
2.1.4 The Resolution parameters
According to (Abbatiello et al., 2010), an interference occurs when a transition
other than that being monitored appears within ±0.5-1.0Da of the monitored
transition. The resolution parameters are the different resolutions entered by
researchers into the MRMaid database for m/z tolerance and retention time
(RT) tolerance. The MRMinter database only holds the raw information for
hydrophobicity and is not converted to RT. A formula was derived taking into
account the relationship of hydrophobicity with RT and using this to give a
tolerance value for constant hydrophobicity. According to (Krokhin and Spicer,
2009) the observed retention time of peptides is correlated with their calculated
hydrophobicity through their SSRcalc method. Using the SSRcalc algorithm for
the calculation of hydrophobicity where,
Retention Time = a + b*hydrophobicity where intercept (a) is the gradient delay
time (differs for individual HPLC systems) and slope (b) is a value related to the
slope of acetonitrile gradient (Krokhin and Spicer, 2009).
Using the above equation to estimate tolerance,
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∆H = ∆RT/b. where ∆H is the hydrophobicity tolerance, ∆RT is the Retention 
Time tolerance.
To determine which mass resolutions to consider, the PRIDE database
(Vizcaino et al., 2013), was interrogated to see which combination of precursor
and product tolerance had been used in submitted experimental data. A
summary of this information is shown in Table 1.
Table 1. A table showing the resolution parameters (m/z) used to test the
MRMinter tool. These parameters were derived from the PRIDE database.
Precursor Tolerance (m/z) Product Tolerance (m/z)
0 0
0.04 0.8
0.6 0.4
0.6 0.6
1 0.7
1 0.8
1.5 0.7
1.5 1
2.5 0.7
3 0
2.1.5 Evaluation of the database
The database content was evaluated and the system was tested using data
from (Anderson and Hunter 2006) and datasets from the MRMaid transition
database. The Anderson and Hunter study was aimed at studying proteotypic
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peptides and showing the importance of choosing the right peptides to use in
SRM based transition design. The proteotypic peptides were run through the
database with a query to identify the transition interferences using the tolerance
parameters shown above. The Anderson and Hunter study involved 57 proteins
and 137 transitions. 18 transitions were stable isotope labelled transitions and
these were analysed to judge how useful this tool would be in supporting
common absolute quantification methods. Using a SIS labelled transition is a
great tool for quantification and is an important factor along with the
measurement of the intensity of interferences in validating transitions.
The datasets from the MRMaid transition database were used also to test the
MRMinter database. These transitions were peptide transitions from the human
proteome and of the 404,000 transitions available the system was able to
recognize and test 402,975 transitions.
Using a database populated with the peptides obtained from theoretically
digesting proteins from a proteome sourced from a database repository, can
sometimes mean that there is the assumption that the peptide to be queried
against is available within the database. Therefore the probability that there will
be no result from the query exists.
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3 Results and Discussion
3.1 The MRMinter database
This thesis aim is to investigate the issue of interfering transitions in SRM
experiments. This is achieved through the process of building a peptide
database (MRMinter) housing theoretical transitions and using the information
to select transitions with precursor and product ions with signals close to the
original transitions being designed. MRMinter will be able to assist the
researcher performing an SRM assay experiment, in determining the
uniqueness of the peptide being monitored. This is achieved by cross-checking
the transitions being monitored against the proteome from which the sample is
derived, highlighting the count of observed interferences, their description;
peptide sequence, hydrophobicity, precursor m/z, precursor charge, product
m/z, product type and product number. In order for the investigation of
interferences to be performed, a theoretical tryptic digest of the proteome was
conducted and this yielded peptides which provided the information for the
transitions. This information is in the form of precursor ion m/z and product ion
m/z. To increase the specificity of the results, the hydrophobicity of the parent
peptide is considered. This monitoring of the hydrophobicity and by extension
the elution time of the peptide reduces the number of false positives that the
algorithm would raise. The representation of the tryptic peptides between 3 to
30 amino acids is shown in Table 2. An SRM experiment is ideal for peptides
between 8-25 amino acids residues. The reason for choosing 3-30 amino acid
residues within the database is to serve as an adequate background to search
against.
Table 2. A summary of the content of the different tables in the MRMinter
database. Most of the data is a derivation from information in peptide table.
Shown is the count of Proteins, Peptides, Precursor ions and Product ions.
Protein Peptide Precursor Product
20,220 870,192 2,610,576 17,015,452
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The definition of the transitions that occur in a QQQ peptide fragmentation is an
essential step in SRM assay development, (de Graaf et al., 2011). The
interference issue is a measure of the specificity and selectivity of a transition.
This can be described also in terms of the uniqueness of a transition and may
be related to the characteristics of the parent peptide. Thus the knowledge of
the probability of another peptide possessing the same characteristics as the
target peptide is very important. This information also helps in the choice of
method in the SRM experiment. The MRMinter database is able to assist
researchers increase the selectivity of their methods by having previous
knowledge of possible peptides sharing similar properties. The selectivity of the
precursor ions, the product ions and the hydrophobicity within a proteome is
important. This can be shown as the probability of the occurrence of peptides
showing identical values in the form of the same precursor ions, product ions
and hydrophobicity. The selectivity of the above values in table 2 within the
MRMinter database is measured to give a frequency distribution of transitions
within the MRMaid database. MRMinter can help researchers to obtain a picture
of the probability of occurrence of a transition having the same SRM behaviour
as their transition of interest. This is accomplished by taking into account the
individual probabilities of the precursor m/z, the product m/z and hydrophobicity,
to give the total probability of having an interfering transition within a result set.
According to (Berendsen et al., 2013) the disadvantage of analysing these data
by using independent probability statistics is that dependency of the data is
assumed to be non-existent. One of the main dependencies that exist is the
charge ratio of the precursor ion and the fact that singly charged precursor ions
produce product ions with a lower m/z. As a result of this using independent
probability statistics in this analysis does not allow for precise measurement of
probability but only an indication of the value of selectivity.
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Figure 8. The probability distribution of the hydrophobicity of the peptides. The
hydrophobicity was calculated according to Krokhin et al, 2004. Using SSRcalc
resulted in some peptides with negative hydrophobicity values.
Figure 8 shows the distribution of the hydrophobicity values within the database.
It is observed that the majority of peptides carry a hydrophobicity of 10 units
which ensures that elution through a high performance liquid chromatography
column is possible and can be used to aid in the selectivity process of SRM.
Using the SSRcalc algorithm results in negative values for hydrophobicity for
some tryptic peptides. For example tryptic peptide QPPSNPPPRPPAEAR from
the protein Cytochrome b-245 light chain has a hydrophobicity value of -1 when
calculated with SSRcalc. This should not present a problem in the SRM
perspective. The reason is that an offset is added when converting
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hydrophobicity to retention time (RT) which means we do not have to worry
about negative RTs.
Figure 9. The probability distribution of the precursor ions m/z.
Figure 9 shows the precursor m/z ratio and given the operation of a mass
spectrometer is limited to approximately 3kDa, this shows that the SRM
technique is suitable for working on tryptic peptides within the human proteome
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Figure 10. The frequency distribution of the m/z of the product ions
Figure 10 shows the product ions and their distribution within the human
proteome. The spread of the m/z ratios also show that detecting the product ion
fragments within a SRM experiment is well within the capabilities of the SRM
equipment.
The knowledge of peptides showing the same behaviour in an SRM experiment
and the probability of them occurring together can be estimated theoretically.
This can be of great assistance to researchers by helping them choose the
appropriate SRM parameters in tune with their method and equipment.
As explained earlier a transition is the combination of a peptide’s precursor ion
m/z and its corresponding fragment ion. Figure 11 below shows a bitmapped
image of the relationship of all possible transitions within the MRMinter
database. This relationship is reflective of the tryptic nature of the peptides. The
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total possible number of transitions within the database come to a total of
51,046,356. This figure represents the combination of number of precursor ions,
charge state 1, 2 and 3 with the number of product ions, Table 2. This is
encouraging as it means that detecting most of the possible interferences that a
transition encounters is theoretically possible. The charge states within the
database are observed as three spikes, peaking at approximately 3000 product
m/z show a correlation to a distribution at 3000, 1500 and 1000 product m/z.
Figure 11 shows the hotspots to avoid when seeking appropriate transitions.
Figure 11. A bitmapped image of the precursor m/z value against the product m/z
value of all the peptides contained within the MRMinter database.
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3.2 Effect of mass tolerance and chromatographic resolution on
interference (Using Anderson and Hunter 2006 transitions).
Anderson and Hunter carried out a study to assess the performance of the
MRMs in various typical digest experiments. In the study the value of high and
medium abundance plasma proteins as biomarkers makes a case for the
application of specific MRM assays. The aim of the study was to find out if MRM
assays could be used to quantify the plasma proteins count and to determine
the measurement precision. Assays were designed for the purpose of
measuring tryptic peptides. The peptides represented 53 high to medium
abundance proteins (see Table 4) in human plasma. 137 transitions were
derived from the 60 tryptic peptides. Of those 137 transitions, 18 were Stable
isotope labelled Standards (SIS). The study was able to demonstrate the
accuracy possible using the MRM technique by producing significant
quantitative data.
The computational approach to predicting the unique existence of a transition
according to (Picotti et al., 2013) is an alternative to experimental methods. By
comparing the target transitions with all the other transitions present within the
database and generating a list of matches, MRMinter aims to contribute to
assay design by increasing specificity through the identification of possible
interferences for a given transition.
The search is performed by looking at a range of values within the specified
tolerance and any matches indicate an interfering transition. The peptide
tolerance, (the error window on experimental peptide mass values) is
dependent on the mass spectrometer used and the accuracy of the calibration.
This is a case whereby error tolerant searches are permitted in order to find the
most optimal tolerance setting that SRM equipment can utilize without losing
throughput. The m/z windows which make up the resolution in which the SRM
scans each individual transition, allows for increased sensitivity or a dynamic
range of one to two orders of magnitude (Shi et al., 2012) compared with the full
scan mode of LC-MS/MS. It is of even greater advantage to get the best
resolution to maximise the specificity and sensitivity without losing efficiency.
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Resolutions queried were those most commonly used in PRIDE during
submission of spectra. Below is an example output for a transition and its
interferents.
Table 3. An example output of a transition for peptide EIGELYLPK and its
interferents. The resolution used is tolerance of 1 for the precursor m/z, 0.7 for
the product m/z and 1 hydrophobic unit.
Peptide sequence hydrophobicity Precursor
m/z
Precursor
charge
Product
m/z
Product
type
Product
number
Target : EIGELYLPK
29.6084 531.3 2 633.4 Y 5
interferents
GMEEGEDNLLCNLR 29.04 531.6 2 633.22 B 6
EQIDLAAR 29.35 531.78 2 633.29 B 5
VYAVEASAIWQQAR 29.66 531.28 3 633.32 B 6
ALEFATLAAR 29.74 571.80 2 633.32 B 6
Table 3 shows an example of a target transition and the interferences it
encounters at a particular resolution. Due to the nature of isobaric peptides,
filtering out interferences from transitions requires more than just the knowledge
of the precursor m/z and product m/z. The hydrophobicity of the peptide
sequence plays a very important role in the process. The Retention time is
defined as the time it takes for the peptide sequence to elute through the
chromatography column and as it is a function of the hydrophobicity of the
peptide, it is a major defining factor in distinguishing the transition being
observed from any similar signals. Early bioinformatics forays into predicting the
interference encountered by transitions, did not take into account the
chromatographic behaviour or fragmentation properties of individual peptides
(Picotti and Aebersold, 2012).
In the (Anderson and Hunter, 2006) study, 53 proteins were studied. Out of
these proteins six of them were not reliably observed. These peptides and their
transitions have been validated and studied using stable – isotope labelled
peptides. The transitions were run through the database for the ten different
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precursor and product tolerance settings most queried in the MRMaid pride
database search. For the precursor and product tolerance settings three
different hydrophobicity tolerance settings were queried, a tolerance of 1, 2 and
3. These hydrophobicity tolerances are the windows of hydrophobicity searched
within the database for the peptide from which the transition is derived. Figure
12 is a graph which highlights the total number of interferences for the different
precursor, product and hydrophobicity tolerances.
Figure 12. Total number of interferences per transition measured by MRMinter
for the different precursor m/z, product m/z and hydrophobicity resolutions
using the Anderson and Hunter 2006 dataset. The hydrophobicity tolerance 1, 2
and 3 units.
As expected the result shows that the higher the resolution the less the number
of interferents. Also it can be assumed that hydrophobicity has a direct co-
relation as the interferent counts increased almost exponentially with an
increase in tolerance. This same effect was not as pronounced for the precursor
m/z and product m/z.
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Table 4. A set of the 53 proteins used in the Anderson and Hunter, 2006 study.
Also included are the peptides. The transitions used in the study were derived
from these peptides.
No Protein Peptide
1 Afamin DADPDTFFAK
2 Alpha-1-acid glycoprotein 1 NWGLSVYADKPETTK
3 Alpha-1-antichymotrypsin EIGELYLPK
4 Alpha-1B-glycoprotein LETPDFQLFK
5 Alpha-2-antiplasmin LGNQEPGGQTALK
6 Alpha-1-antitrypsin DTEEEDFHVDQVTTVK
7 Alpha-2-macroglbulin LLIYAVLPTGDVIGDSAK
8 Angiotensinogen ALQDQLVLVAAK
9 Angiotensinogen PKDPTFIPAPIQAK
10 Antithrombin-III DDLYVSDAFHK
11 Apolipoprotein A-I ATEHLSTLSEK
12 Apolipoprotein A-II precursor SPELQAEAK
13 Apolipoprotein A-IV SLAPYAQDTQEK
14 Apolipoprotein B-100 FPEVDVLTK
15 Apolipoprotein B-100 TEVIPPLIENR
16 Apolipoprotein C-I lipoprotein TPDVSSALDK
17 Apolipoprotein C-II lipoprotein STAAMSTYTGIFTDQVLSVLK
18 Apolipoprotein C-III DALSSVQESQVAQQAR
19 Apolipoprotein E LGPLVEQGR
20 Beta-2-glycoprotein I ATVVYQGER
21 Beta-2-glycoprotein I EHSSLAFWK
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22 C4b-binding protein alpha LSLEIEQLELQR
23 Ceruloplasmin EYTDASFTNR
24 Clusterin LFDSDPITVTVPVEVSR
25 Coagulation factor V DPPSDLLLLK
26 Coagulation factor XIIa light chain VVGGLVALR
27 Complement C3 TGLQEVEVK
28 Complement C4 gamma chain ITQVLHFTK
29 Complement C4 beta chain VGDTLNLNLR
30 Complement C9 AIEDYINEFSVR
31 Complement factor B EELLPAQDIK
32 Complement factor H SPDVINGSPISQK
33 Fibrinogen alpha chain TVIGPDGHK
34 Fibrinogen alpha chain GSESGIFTNTK
35 Fibrinogen beta chain QGFGNVATNTDGK
36 Fibrinogen gamma chain DTVQIHDITGK
37 Fibronectin DLQFVEVTDVK
38 Fibronectin VTWAPPPSIDLTNFLVR
39 Gelsolin isoform I TGAQELLR
40 Haptoglobin beta chain VGYVSGWGR
41 Hemopexin NFPSPVDAAFR
42 Heparin cofactor II TLEAQLTPR
43 Histidine-rich glycoprotein DSPVLIDFFEDTER
44 Inter-alpha-trypsin inhibitor heavy chain AAISGENAGLVR
45 Inter-alpha-trypsin inhibitor light chain AFIQLWAFDAVK
46 Kininogen TVGSDTFYSFK
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47 L-selectin AEIEYLEK
48 Plasma retinol-binding protein YWGVASFLQK
49 Plasminogen LSSPAVITDK
50 Plasminogen LFLEPTR
51 Prothrombin ETAASLLQAGYK
52 Serum albumin LVNEVTEFAK
53 Serum amyloid P-component VGEYSLYIGR
54 Transferrin EDPQTFYYAVAVVK
55 Transthyretin AADDTWEPFASGK
56 Vitamin D-binding protein THLPEVFLSK
57 Vitamin K-dependent protein C WELDLDIK
58 Vitronectin DVWGIEGPIDAAFTR
59 Vitronectin FEDGVLDPDYPR
60 Zinc-alpha-2-glycoprotein EIPAWVPFDPAAQITK
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Figure 13. The number of interferents and the frequency with which they occur
across the test sample. In this case 119 transitions were taken from Anderson
and Hunter 2006. The measurements are for 1 hydrophobicity unit and all ten
resolutions specified in Chapter 2, page 39.
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Figure 14. The number of interferents and the frequency with which they occur
across the test sample. The transitions are 18 Stable isotope-labelled internal
standard (SIS) peptide transitions taken from Anderson and Hunter 2006. The
measurements are for 1 hydrophobicity unit and all ten resolutions specified in
Chapter 2, page 39.
The first aspect of this study was to find out if the database was able to return
any interferences for transitions given a resolution. In an experimental setting a
transition's interference will be easily quantified as the desired transition
because it will demonstrate close precursor m/z and product m/z values and
elute at a retention time very close to that of the specified transition (Yan et al.,
2008).
As expected we see almost no interferents for the high resolution setting of (0
precursor and 0 product), figure 13a. Although the tolerance settings of 0 m/z
for the product and precursor ions is practically impossible, it has been included
as a theoretical case. The most used resolutions, fig 13c and 13d and figure
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13b return more interferences but the 0.04 precursor tolerance 0.8 product
(figure 13b) resolution’s interference values are a lot less showing the
importance of the precursor tolerance settings. The (1 precursor and 0.7 and
0.8 product) tolerance, fig 13 e and f also highlight the significance of precursor
tolerance as compared to the previous tolerance values a higher precursor
tolerance results in more interferences. The (3 precursor and 0 product)
tolerance figure 13j also shows very low interference numbers. Considering the
sensitivity of SRM equipment it is highly likely that that is a setting that will not
be viable to many researchers. The (1.5 precursor and 0.7 and 1 product)
tolerances figures 13g and 13h and (2.5 precursor and 0.7 product) tolerance
figure 13i show that low resolutions which is normal for older instruments,
increase the possibility of introducing errors into the results through inaccurate
selection of transitions. This highlights the balance that researchers are trying to
keep between sensitivity of the instrument settings and throughput. There might
also be a case for the importance of the product m/z tolerance settings as the
increase in this is more significant than the increase in the precursor tolerance.
This can be seen in the tolerance of (1.5 precursor and 1 product) which gives
the highest output of interferences of all the resolutions queried. When the
precursor tolerance is increased to (2.5 and product tolerance is .7) the output
of interferences is still far below that of the (1.5 precursor and 1 product)
resolution. An interesting resolution used is that of tolerance precursor of 3 and
product tolerance of 0. There is still a very high output of interferences which
means that the upper range of the product m/z tolerance of 0.7 to 1 is where a
lot of interferences can be observed.
The analysis was also carried out with 18 Stable isotope-labelled internal
standard (SIS) peptides. The distribution of the graphs show that the precursor
tolerance is still a very important factor in the observance of interferences.
Figure 14i shows that even with a product tolerance of 0.7, the precursor
tolerance of 2.5 results in the most interferences in the analysis of the SIS
peptide transitions derived from the (Anderson and Hunter, 2006) study. The
main point is the fact that the algorithm is able to find transitions that interfere
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with SIS transitions. The fact that the number of interferents are strongly related
to the resolution tolerance gives more confidence in the tool.
3.3 Effect of mass tolerance and chromatographic resolution on
interference (Using MRMaid transitions).
Figure 12 clearly shows that the tolerances increase at an almost exponential
level with every increase in tolerance by 1 unit. Therefore the decision was
taken to study the effect of hydrophobicity tolerance on the MRMaid data only
up to a tolerance of 2 hydrophobic units.
Figure 15. Total number of interferences per transition measured by MRMinter
for the different precursor m/z, product m/z and hydrophobicity resolutions
using the MRMaid dataset.
Using the Anderson and Hunter transitions only covered a minute fraction of
possible transitions. For example in the MRMaid transition database there are
473,373 transitions for the species Arabidopsis (Fan et al., 2012). The human
proteome is the subject of study in this thesis and from the MRMaid transition
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database 404,000 transitions were retrieved. Of these, 402,975 transitions
matched with the MRMinter database. The reason for the difference is that the
remainder transitions had precursor ions with a charge state of 4 or higher.
While this is useful in certain circumstances SRM experiments performed with
precursor ions of higher charge states do not give the most accurate results.
Transitions with peptide lengths of 7-25 amino acids were queried against the
MRMinter database to retrieve interferences. 397757 transitions were analysed.
The results are shown in Figure 16a-j.
Using the same resolution as that used against the Anderson and Hunter data,
it is observed that the resolution with the least number of interferences is 0
precursor and 0 product (figure 16a) which is to be expected as these values
are theoretical and only serve to provide a standard to measure against. The
0.04 precursor and 0.8 product (figure 16b) resolution returned the second
lowest number of interferences. Of the remainder resolutions the 0.6 precursor
and 0.4 product (figure 16c) and 0.6 precursor and 0.6 product (figure 16d)
returned the same number of interferences. The use of the 3 precursor and 0
product resolution which seemed to show in the Anderson and Hunter data set,
that it was possible to allow such a high tolerance of 3 for the precursor with a
product tolerance of 0, returned a higher number of interferences. This is
consistent with expectation. For example in the MRMinter human proteome
database of 20,220 proteins there are over 870,000 peptides with missed
cleavages not considered. In a similar study with a database of approximately
the same size, (Li et al., 2009) found that a single precursor ion will match to
about 600 peptides within the database if the query is based on a tolerance of
1Da. Therefore even when the product tolerance is still set to 0, the high
precursor tolerance will result in a high number of interferences. The best
recommended resolutions figure 16b, c and d also contain the most transitions
with 0 number of interferences. This is useful when designing SRM experiments
as a researcher will like to choose peptides that have at least one transition with
0 interferences.
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16i 16j
Figure 16. The number of interferences and the frequency with which they occur
across the test sample. Transitions in this dataset were obtained from MRMaid.
The measurements are for all ten resolutions specified in Chapter 2, page 39.
3.4 MRMInter a step toward better transition selection.
The MRMinter system was developed from a need to increase the selectivity
and specificity of SRM assays.
Generally in order to increase specificity multiple fragment ions are selected for
each peptide as this reduces the possibility of interferences. MRMinter can help
this process by removing the need to select multiple fragment ions as the
interferences can be filtered out directly. This is discussed by (Rost et al., 2012)
and (Sherman et al., 2009). (Sherman et al., 2009) have tried to explain the
need for directed selection of SRM by dealing with interferences.
The results described in 3.3 have shown that the SRM method is possible but
researchers have to be careful to choose the right transitions.
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The hope is that this work will allow the MRMaid tool to be able to provide a
better SRM design platform for researchers and allow the researchers measure
the suitability of transitions based on the interferences they encounter from
other peptide transitions.
Knowing the coordinates of the interferences will also allow the instrument
makers to pre-program those data points for the assay and maximize dwell time
(Holman et al., 2012).
(Holman et al., 2012) make a case for selecting transitions. They argue that
rather than pre-programming a SRM instrument with the coordinates for
interfering peptides in order to filter them out. The best way is to originally
choose transitions where the product ion m/z is greater than the precursor ion
m/z. The main premise for this is that co-eluting singly charged precursor ions
that may interfere at the first quadrupole will inevitably be filtered out in the
second quadrupole. Thus increasing selectivity and removing interference.
As observed by (Rost et al., 2012) the understanding of the interference
problem can help researchers better understand the fact that identifying a
peptide just by monitoring one transition may not by feasible. This may be due
to the fact that assay redundancy can become a hurdle when designing and
measuring SRM-assays for a given peptide in a highly complex background.
The analysis of data in the MRMinter database has shown that there is a great
probability of encountering interferences within a sample matrix of proteins and
having prior information to aid with the assay design phase will afford
researchers a higher degree of freedom.
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4 Conclusion
A database has been built and accompanying software algorithms have been
developed to assist the MRMaid transition software design program. By virtue of
developing the database I was able to discover that the SRM method is a viable
method that can be improved with knowledge of interfering transitions. In
addition to providing optimal transitions for SRM assays, with this new addition
MRMinter, more information regarding interfering peptides can be provided.
SRM tools are using spectral libraries to generate their transition environments
and the advantages of using this are quite clear.
Chapter 1 provided an introduction to the SRM method and its importance in the
field of proteomics. It showed how bioinformatics can be used to make the
process quicker and more accurate. Chapter 2 showed the method by which
project was to be carried out and highlighted the process of building and
manipulating a database to return theoretical results that closely mirror
experimental settings. An analysis of the results from the database, software
tool and datasets used to test the tool were presented and analysed. As has
been mentioned MRMinter shows clearly that the SRM procedure is a viable
procedure and any errors that may accompany the method can be clearly
controlled with careful observation of the results and experimental conditions.
As long as the peptide is tryptic and between 3-30 sequences long then it will
be within the database along with its corresponding data. As mentioned by
(Rost et al., 2012) results that are returned by the database are subject to the
data acquired from Swiss-Prot thus increasing the chances of false negatives.
The false negatives are interferences that cannot be detected due to factors
outside our control. Decreasing the occurrence of false negative hits might
involve allowing for missed cleavages modifications within the peptide
sequence and monitoring other ions other than the b and y ions.
The tool helps move towards completely automated SRM assay design and
data analysis. The use of the various tools such as Perl programming language
have made the manipulation of data and the ability to connect to the database
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using the Perl DBD module has allowed the generation of results sets in formats
that are easy to manipulate and analyse. For example connecting to MySQL
through Perl has allowed the downloading of .csv files that would not have been
easy through MySQL alone. A drawback with Perl is that it does not have the
speed of languages such as java and C++. This can affect the time taken to
generate the required data.
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5 Future Work
For the real generation of an adequate system to aid the design of SRM assays
all the scenarios that can occur with respect to the manipulation of proteins via
mass spectrometry should be taken into account for example, missed
cleavages are a common occurrence in experimental settings as the digestive
enzyme might not get 100% coverage of the sample to purification. This can
affect protein abundance and by extension quantitation. Immonium ions
observed under high energy dissociation must also be taken into account. A lot
of SRM experiments are carried out on triple quadrupole spectrometers and low
energy CID is used to fragment the precursor ions and though we can expect
only y ions and low m/z b ions, other ion fragments can be programmed as an
option for researchers to choose from especially if they are working with other
types of mass spectrometers and fragmentation takes place by Electron
Capture Dissociation etc. They then encounter fragment ions like a, z and c
fragment ions. Having a database of interferences for peptides from post
translational modified proteins may be appropriate. This may mean that the
MRMinter database may have to deviate from its original function as a tool to
assist the MRMaid software due to the fact that the MRMaid software does not
consider factors like missed cleavages or modified peptides. The MRMinter
database can then be further developed into a stand-alone web-based software
that can be queried online for interference information.
The database can also be extended to cater for other species and this would
also have the added benefit of more robust analysis of the transition
interference issue and selectivity. In Mass spectrometry there are peptides
which are undetectable and some peptides which though detectable have
transitions which cannot be measured. The effect of these peptides can be
studied with the inteferent database.
The interferent database is originally designed as a tool to work with the web-
based MRMaid search program and its main objective is to assist researchers
using the MRMaid program to increase the selectivity of their MRM experiments
by having prior knowledge about the uniqueness of their own transitions.
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The data generated in this thesis only shows the presence or absence of
interferences within the database or proteome. Future work could include
generating enough data to show a clear difference between signal and
background noise. This will provide enough information to allow the instrument
manufacturers to design instruments, with the technology to reduce matrix
interferences without losing signal intensity.
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APPENDICES
Appendix A Scripts
A.1 SQL Script for the schema for MRMinter
SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0;
SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS,
FOREIGN_KEY_CHECKS=0;
SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='TRADITIONAL';
CREATE SCHEMA IF NOT EXISTS `MRMInter` DEFAULT CHARACTER SET latin1
COLLATE latin1_swedish_ci ;
USE `MRMInter`;
-- -----------------------------------------------------
-- Table `MRMInter`.`peptide`
-- -----------------------------------------------------
CREATE TABLE IF NOT EXISTS `MRMInter`.`peptide` (
`peptide_id` INT NOT NULL AUTO_INCREMENT ,
`protein_ac` VARCHAR(9) NOT NULL ,
`peptide_sequence` VARCHAR(45) NOT NULL ,
`hydrophobicity` FLOAT NOT NULL ,
PRIMARY KEY (`peptide_id`) )
ENGINE = InnoDB
COMMENT = 'This table contains peptide sequences';
-- -----------------------------------------------------
-- Table `MRMInter`.`precursor`
-- -----------------------------------------------------
CREATE TABLE IF NOT EXISTS `MRMInter`.`precursor` (
`precursor_id` INT NOT NULL AUTO_INCREMENT ,
`precursor_m/z` FLOAT NOT NULL ,
`precursor_charge` TINYINT NOT NULL ,
`peptide_peptide_id` INT NOT NULL ,
PRIMARY KEY (`precursor_id`, `peptide_peptide_id`) ,
INDEX `fk_precursor_peptide` (`peptide_peptide_id` ASC) ,
CONSTRAINT `fk_precursor_peptide`
FOREIGN KEY (`peptide_peptide_id` )
REFERENCES `MRMInter`.`peptide` (`peptide_id` )
ON DELETE NO ACTION
ON UPDATE NO ACTION)
ENGINE = InnoDB
COMMENT = 'All values related to the precursor ion ';
-- -----------------------------------------------------
-- Table `MRMInter`.`product`
-- -----------------------------------------------------
CREATE TABLE IF NOT EXISTS `MRMInter`.`product` (
`product_id` INT NOT NULL AUTO_INCREMENT ,
`product_m/z` FLOAT NOT NULL ,
`product_type` VARCHAR(1) NOT NULL ,
`product_number` TINYINT NOT NULL ,
`peptide_peptide_id` INT NOT NULL ,
PRIMARY KEY (`product_id`, `peptide_peptide_id`) ,
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INDEX `fk_product_peptide1` (`peptide_peptide_id` ASC) ,
CONSTRAINT `fk_product_peptide1`
FOREIGN KEY (`peptide_peptide_id` )
REFERENCES `MRMInter`.`peptide` (`peptide_id` )
ON DELETE NO ACTION
ON UPDATE NO ACTION)
ENGINE = InnoDB
COMMENT = 'All values related to product ions.';
-- -----------------------------------------------------
-- Table `MRMInter`.`transition`
-- -----------------------------------------------------
CREATE TABLE IF NOT EXISTS `MRMInter`.`transition` (
`transition_id` INT NOT NULL AUTO_INCREMENT ,
`peptide_sequence` VARCHAR(30) NOT NULL ,
`hydrophobicity` FLOAT NOT NULL ,
`precursor_m/z` FLOAT NOT NULL ,
`precursor_charge` TINYINT NOT NULL ,
`product_m/z` FLOAT NOT NULL ,
`product_type` VARCHAR(1) NOT NULL ,
`product_number` TINYINT NOT NULL ,
PRIMARY KEY (`transition_id`) )
ENGINE = InnoDB
COMMENT = 'peptide transitions';
-- -----------------------------------------------------
-- Table `MRMInter`.`interference`
-- -----------------------------------------------------
CREATE TABLE IF NOT EXISTS `MRMInter`.`interference` (
`interference_id` INT NOT NULL AUTO_INCREMENT ,
`peptide_sequence` VARCHAR(30) NOT NULL ,
`hydrophobicity` FLOAT NOT NULL ,
`precursor_m/z` FLOAT NOT NULL ,
`precursor_charge` TINYINT NOT NULL ,
`product_m/z` FLOAT NOT NULL ,
`product_type` VARCHAR(1) NOT NULL ,
`product_number` TINYINT NOT NULL ,
`transition_transition_id` INT NOT NULL ,
PRIMARY KEY (`interference_id`, `transition_transition_id`) ,
INDEX `fk_interference_transition1` (`transition_transition_id` ASC)
,
CONSTRAINT `fk_interference_transition1`
FOREIGN KEY (`transition_transition_id` )
REFERENCES `MRMInter`.`transition` (`transition_id` )
ON DELETE NO ACTION
ON UPDATE NO ACTION)
ENGINE = InnoDB;
SET SQL_MODE=@OLD_SQL_MODE;
SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS;
SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS;
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A.2 Perl Scripts
A.2.1 Populate_mrminter.pl
#! /usr/bin/perl -w
# Author: Oshiobugie Dokpesi
# Date: February 2013
# File: populate_mrminter.pl
# Code Description: Program retrieves FASTA data from file and performs a
theoretical
# trypsin digest on the sequence. From the resulting
peptides only
# those from 3 to 30 amino acids long are selected. The
hydrophobicity,
# precursor charge, precursor m/z, product ion m/z,
production type and number
# values are then calculated and with the protein accession
number and peptide sequence
# inserted into the MRMinter database.
#
use strict;
use Data::Dumper;
use DBI;
use DBD::mysql;
my $hat;
my $i;
my $pep_hydro;
my $pepmass;
my $pep;
my $mz_1;
my $mz_2;
my $mz_3;
my $seq = '';
my $hot;
my %sequence = %{ read_fasta_as_hash('humans.fasta') };
foreach my $id ( keys %sequence ) {
my ($tmp, $Access, $ID) = split(/\|/, $id);
if ($ID =~ /(\d+\w_\w+)/){
my $name = $1;
}
# The protein sequence is digested using a regex that simulates the action
#of the enzyme trypsin
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my @seq = split(/(?!P)(?<=[RK])/, $sequence{$id});
# peptides that are greater than 2 AAs and less than or equal to 24 AAs are
chosen.
@seq = grep { length ($_) >= 3 && length ($_) <= 24 } @seq;
#The peptides are then sorted in a list from shortest to longest.
foreach $seq(@seq){
chomp ($seq);
$hat = hydro($seq);
if ($hat < 38) {
$hot = $hat;
}elsif ($hat >= 38) {
$hot = $hat - 0.3*($hat - 38);
}
print " hydrophobicity is $hot \n";
my $pepmaster = mz_ratio($seq);
print " The mass $seq is $pepmaster g \n";
# mass-charge ratio is sum of residue masses + hydrogen divided by charge
# CSID:1010, http://www.chemspider.com/Chemical-Structure.1010.html (accessed
23:06, Oct 26, 2012)for mass of hydrogen atom (da)
$mz_1 = ($pepmaster+1.007276)/1;
$mz_2 = ($pepmaster+2.014552)/2;
$mz_3 = ($pepmaster+3.021828)/3;
print " charge1 :$mz_1 , charge2: $mz_2, charge3: $mz_3 \n";
# convert the peptide sequence to mass of ions using subroutines.
# change mass of ions in array to hash
# change my b ions from array to hash value with the array position + 1 to
# represent the ion number. This number is then made into a key with the mass
as value.
my @b_ions = pep_mass_bions($seq);
my %hb_ions = ();
for ($i=0; $i<scalar(@b_ions); $i++){
$hb_ions{$i+1} = $b_ions[$i];
}
# change my y ions from array to hash value with the array position + 1 to
# represent the ion number. This number is then made into a key with the mass
as value.
my @y_ions = pep_mass_yions($seq);
my %hy_ions = ();
for ($i=0; $i<scalar(@y_ions); $i++){
$hy_ions{$i +1} = $y_ions[$i];
}
# The hash for B ions
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print "\n This is the hash for my b ions: \n\n";
while ( my ($key, $value) = each(%hb_ions) ) {
print "B|$key|$value\n";
}
# The hash for Y ions
print "\n This is the hash for my y ions: \n\n";
while ( my ($key, $value) = each(%hy_ions) ) {
print "Y|$key|$value\n";
}
my $ds = "DBI:mysql:mrminterest:localhost";
my $user = "root";
my $passwd = "Peptide5";
my $dbh = DBI->connect($ds,$user,$passwd) || die "Can't
Connect!";
# prepare an SQL statement
# insert into peptide table
my $sth = $dbh->prepare("insert into peptide (protein_ac,
peptide_sequence, hydrophobicity) values (?,?,?)");
$sth->execute( $Access, $seq, $hot);
# to get the primary key from the peptide table and insert it into the
foriegn keys of your child tables
my $table_key = $dbh->{'mysql_insertid'};
# insert into precursor table
my $sth2 = $dbh->prepare("insert into precursor (precursor_m/z,
precursor_charge, peptide_peptide_id) values (?,?,?)");
$sth2->execute( $mz_1, 1, $table_key);
$sth2->execute( $mz_2, 2, $table_key);
$sth2->execute( $mz_3, 3, $table_key);
# insert into product table a while loop is used to loop over the hash and
retrieve values from it
my $sth3 = $dbh->prepare("insert into product ( product_m/z,
product_type, product_number, peptide_peptide_id) values (?,?,?,?)");
while ( my ($key, $value) = each(%hb_ions) ) {
$sth3->execute ($value, 'B', $key, $table_key );
}
while ( my ($key, $value) = each(%hy_ions) ) {
$sth3->execute ($value, 'Y', $key, $table_key );
}
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# finish in order to
$sth->finish;
$sth2->finish;
$sth3->finish;
$dbh->disconnect;
}
}
sub read_fasta_as_hash {
my $fn = shift;
my $current_id = '';
my %seqs;
open FILE, "<$fn" or die $!;
while ( my $line = <FILE> ) {
chomp $line;
if ( $line =~ /^(>.*)$/ ) {
$current_id = $1;
} elsif ( $line !~ /^\s*$/ ) { # skip blank lines
$seqs{$current_id} .= $line
}
}
close FILE or die $!;
return \%seqs;
}
# To calculate the hydrophobicity, the hydrophobicity model developed by
Krokhin et al is used. The values for the retention cooefficients are
substituted for the amino acids and calculated as follows.
sub hydro {
my ($pep_seq) = @_;
my $pep;
my $pep_hydro = 0;
my $Kl = 0;
my $sumRc = 0;
my $len = length ($pep_seq);
# To calculate the sum of all the amino acids
for (my $i =0; $i< $len; $i += 1) {
$pep = substr ($pep_seq, $i, 1);
$sumRc += hyd($pep);
}
# To calculate the hydrophobicity H = Kl*(sumRc + 0.42(R1cNt) + 0.22(R2cNt) +
0.05(R3cNt))
my $R1 = .42 * Rcnt(substr($pep_seq, 0, 1));
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my $R2 = .22 * Rcnt(substr($pep_seq, 1, 1));
my $R3 = .05 * Rcnt(substr($pep_seq, 2, 1));
# Taking into account the correction coefficient and reflecting the influence
of peptide length
if ($len < 10) {
$Kl = 1-0.027*(10-$len);
}elsif ($len > 20) {
$Kl = 1-0.014*($len-20);
}else {
$Kl = 1;
}
$pep_hydro = $Kl*($sumRc + $R1 + $R2 + $R3 );
return $pep_hydro;
}
# To obtain the mass charge ratio, the mass of the peptide is first
calculated
# Take a count of the respective amino acids and multiply the total count of
each individual AA by the mass of the amino acids.
# add all together plus the mass of water molecule to give the total mass for
the peptide.
sub m/z_ratio {
my ($pep_seq) = @_;
my $pep;
my $pepmass;
for (my $i =0; $i< length($pep_seq) ; $i += 1) {
$pep = substr ($pep_seq, $i, 1);
$pepmass += AAmass($pep);
}
$pepmass = $pepmass + 18.01056;
return $pepmass ;
}
# the b ions are the sum of the residue masses from the first AA (amino acid)
on the N->C direction in the peptide sequence to the last AA plus (1( the
mass of the hydrogen atom)).
# this can be achieved by taking the first AA add 1 and store as b1, then b2
= b1+(2nd AA), b(n) = bn-1+(last AA)
# subroutine to calculate the B product_ion masses given a peptide sequence.
sub pep_mass_bions {
my ($pep_seq) = @_;
my @AAs;
my $bmass;
my @bmass;
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# use the split function to break up the string into an array
# loop through the array and calculate the ions.
@AAs = split( "", $pep_seq);
for ($i = 0; $i< scalar(@AAs); $i++){
if ($i == 0) {
$bmass = AAmass($AAs[$i]) + 1.007276;
push (@bmass, $bmass);
} else{
$bmass = $bmass + AAmass($AAs[$i]);
push (@bmass, $bmass);
}
}
return @bmass ;
}
# the y ions are the sum of the residue masses from the first AA (amino acid)
on the C->N direction in the peptide sequence to the lasr AA plus (19 ( the
mass of water and hydrogen atom)).
# this can be achieved by reversing the peptide sequence first, then taking
the first AA add 19 and store as y1, the y2 = y1+(2nd AA, y(n) = y(n-1)+(last
AA).
# subroutine to calculate the Y product_ion masses given a peptide sequence.
sub pep_mass_yions {
# my input peptide sequence
my ($pep_seq) = @_;
# my reversed peptide sequence to generate y_ions
my $ypep_seq = reverse($pep_seq);
my @AAs;
my $ymass;
my @ymass;
# use the split function to break up the string into an array
# loop through the array and calculate the ions.
@AAs = split( "", $ypep_seq);
for ($i = 0; $i< scalar(@AAs); $i++){
if ($i == 0) {
$ymass = AAmass($AAs[$i]) + 19.0178407;
push (@ymass, $ymass);
} else{
$ymass = $ymass + AAmass($AAs[$i]);
push (@ymass, $ymass);
}
}
return @ymass ;
}
# subroutine to store the total monisotopic masses of the Amino acids. These
values can be used to calculate
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# the mass of the peptides
sub AAmass {
my ($AAcid) = @_;
my (%AAmass) = (
'A' => 71.037114, #alanine
'C' => 103.00919, #cysteine
'D' => 115.02694, #aspartic_acid
'E' => 129.04259, #glutamic_acid
'F' => 147.06841, #phenyalanine
'H' => 137.05891, #histidine
'I' => 113.08406, #isoleucine
'K' => 128.09496, #lysine
'L' => 113.08406, #leucine
'M' => 131.04049, #methionine
'N' => 114.04293, #asparagine
'P' => 97.052764, #proline
'Q' => 128.05858, #glutamine
'R' => 156.10111, #arginine
'S' => 87.032029, #serine
'G' => 57.021464, #glycine
'T' => 101.04768, #threonine
'V' => 99.068414, #valine
'W' => 186.07931, #tryptophan
'Y' => 163.06333, #tyrosine
'X' => 0, # unknown
'B' => 114.04293, # Asparagine or aspartic acid
'Z' => 128.05858, # Glutamine or glutamic acid
'U' => 150.95364, # Selenocysteine
'O' => 237.14773, # Pyrrolysine
'J' => 113.08406, # leucine or isoleucine
);
# clean up the input
$AAcid =~ s/\n//g;
if (exists $AAmass{$AAcid}) {
return $AAmass{$AAcid};
}else{
print STDERR "bad amino_acid \"$AAcid\"!!\n";
exit;
}
}
# subroutine to store the Retention coefficient values of the Amino acids.
These values are used to calculate
# the hydrophobicity values of the peptides
sub hyd {
my ($AAcid) = @_;
my (%hydro) = (
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'A' => .80, #alanine
'C' => -.80, #cysteine
'D' => -.50, #aspartic_acid
'E' => 0.0, #glutamic_acid
'F' => 10.5, #phenyalanine
'H' => -1.3, #histidine
'I' => 8.4, #isoleucine
'K' => -1.9, #lysine
'L' => 9.6, #leucine
'M' => 5.8, #methionine
'N' => -1.2, #asparagine
'P' => 0.2, #proline
'Q' => -0.9, #glutamine
'R' => -1.3, #arginine
'S' => -0.80, #serine
'G' => -0.90, #glycine
'T' => 0.4, #threonine
'V' => 5.0, #valine
'W' => 11.0, #tryptophan
'Y' => 4.0, #tyrosine
'X' => 0, # unknown
'B' => -1.2, # Asparagine or aspartic acid
'Z' => -0.9, # Glutamine or glutamic acid.
'U' => 0, # Selenocysteine
'O' => 0, # Pyrrolysine
'J' => 8.4, # leucine or isoleucine
);
$AAcid =~ s/\n//g;
if (exists $hydro{$AAcid}) {
return $hydro{$AAcid};
}else{
print STDERR "bad amino_acid \"$AAcid\"!!\n";
exit;
}
}
# subroutine to store the weighted retention coefficients which reflect the
influence of the distance from the N-terminus
# of the Amino acids. These values are used to calculate the hydrophobicity
values of the peptides.
sub Rcnt {
my ($AAcid) = @_;
my (%hydro) = (
'A' => -1.5, #alanine
'C' => 4.0, #cysteine
'D' => 9.0, #aspartic_acid
'E' => 7.0, #glutamic_acid
'F' => -7.0, #phenyalanine
'H' => 4.0, #histidine
'I' => -8.0, #isoleucine
'K' => 4.6, #lysine
'L' => -9.0, #leucine
'M' => -5.5, #methionine
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'N' => 5.0, #asparagine
'P' => 4.0, #proline
'Q' => 1.0, #glutamine
'R' => 8.0, #arginine
'S' => 5.0, #serine
'G' => 5.0, #glycine
'T' => 5.0, #threonine
'V' => -5.5, #valine
'W' => -4.0, #tryptophan
'Y' => -3.0, #tyrosine
'X' => 0, # unknown
'B' => 5.0, # Asparagine or aspartic acid
'Z' => 1.0, # Glutamine or glutamic acid
'U' => 0, # Selenocysteine
'O' => 0, # Pyrrolysine
'J' => -8.0, # leucine or isoleucine
);
$AAcid =~ s/\n//g;
if (exists $hydro{$AAcid}) {
return $hydro{$AAcid};
}else{
print STDERR "bad amino_acid \"$AAcid\"!\n";
exit;
}
}
A.2.2 Populate_mrminter_transitions.pl
#! /usr/bin/perl -w
# Author: Oshiobugie Dokpesi
# Date: February 2013
# File: populate_mrminter_transitions.pl
# Code Description: Program retrieves transitions data from Mrmaid and uses
the data to populate the transitions table
# and find interferences for those transitions. those
interferences are then inserted into the interference table.
#
#
#
92
use strict;
use DBI;
use DBD::mysql;
my $peptide_sequencess;
my $RTs;
my $prec_m/z;
my $prec_charge;
my $prod_m/z;
my $product_typ;
my $product_numbe;
my $Peptide;
my $upper_tolerancepre;
my $lower_tolerancepre;
my $upper_tolerancepro;
my $lower_tolerancepro;
my $upper_toleranceRT;
my $lower_toleranceRT ;
# get the search terms to add to the select statement
print " please enter your precursor tolerance \n";
my $tolerance_precursor = <STDIN>;
print " please enter your product tolerance \n";
my $tolerance_product = <STDIN>;
print " please enter your hydrophobicity tolerance \n";
my $tolerance_RT = <STDIN>;
print "Please wait while your data is being processed \n";
# Connect to MRMaid database
# Retrieve transition data from MRMaid database
my $dsn = "DBI:mysql:mrmaid:globe.ccc.cranfield.ac.uk";
my $user1 = "password";
my $passwdd = "password";
my $dbh = DBI->connect($dsn,$user1,$passwdd) || die "Can't Connect!";
# Prepare select statement.
my $statemente = qq{select distinct Peptide.sequence, Precursor.charge,
Fragment.type, Fragment.serial from Peptide, PeptideFragment, Fragment,
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Precursor, Transition where Peptide.species = 'Human' and Peptide.id =
PeptideFragment.peptideID and PeptideFragment.fragmentID = Fragment.id and
Fragment.id = Transition.fragmentID and Transition.precursorID =
Precursor.id;};
my $sth1 = $dbh->prepare($statemente) || die "Cannot prepare
statement:" . DBI->errstr;
$sth1->execute() || die "Cannot execute statement:" . DBI->errstr;
# retrieve required values from database
while (my @response = $sth1->fetchrow_array()){
my $peptide_sequences = $response[0];
my $prec_charge= $response[1];
my $f_type = $response[2];
my $f_serial = $response[3];
print "$peptide_sequences\t$prec_charge\t$f_type\t$f_serial\n";
# connect to MRMinter database
my $ds = "DBI:mysql:mrminter:localhost";
my $user = "root";
my $passwd = "password";
my $dbh = DBI->connect($ds,$user,$passwd) || die "Can't
Connect!";
# Prepare select statement to retrieve hydrophobicity, precursor charge
precursor m/z and product m/z values from MRMinter using
# transition information from MRMaid
my $statement = qq{select distinct peptide.peptide_sequence,
peptide.hydrophobicity, precursor.precursor_m/z, precursor.precursor_charge,
product.product_m/z, product.product_type, product.product_number from
peptide join precursor on peptide.peptide_id =
precursor.peptide_peptide_id join product on peptide.peptide_id =
product.peptide_peptide_id where peptide_sequence = '$peptide_sequences' and
precursor_charge = '$prec_charge' and product_type = '$f_type' and
product_number = '$f_serial';};
my $sth2 = $dbh->prepare($statement) || die "Cannot prepare
statement:" . DBI->errstr;
$sth2->execute() || die "Cannot execute statement:" . DBI-
>errstr;
# retrieve required values from database
while (my @response = $sth2->fetchrow_array()){
$peptide_sequencess = $response[0];
$RTs = $response[1];
$prec_m/z = $response[2];
$prec_charge = $response[3];
$prod_m/z = $response[4];
$product_typ = $response[5];
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$product_numbe = $response[6];
# Insert theoretical transition values matching MRMaid transtion values inot
transitions table in MRMinter
my $sth3 = $dbh->prepare("insert into transitions(peptide_sequence,
hydrophobicity, precursor_m/z, precursor_charge, product_m/z, product_type,
product_number) values(?,?,?,?,?,?,?)");
$sth3->execute( $peptide_sequencess, $RTs, $prec_m/z, $prec_charge,
$prod_m/z, $product_typ, $product_numbe);
# to get the primary key from the transitions table and insert it into the
foriegn keys of your child tables
my $table_key = $dbh->{'mysql_insertid'};
# using the tolerance values inputted by to produce upper range and lower
range of values a required by select statement
# for this project tolerance values used are +-3Da for precursor ion, +-1.1Da
for product ion and 3 units for hydrophobicity
# to cover the resolutions used by scientists when inputting spectra into
PRIDE.
my $upper_tolerancepre = $prec_m/z + $tolerance_precursor;
my $lower_tolerancepre = $prec_m/z - $tolerance_precursor;
my $upper_tolerancepro = $prod_m/z + $tolerance_product;
my $lower_tolerancepro = $prod_m/z - $tolerance_product;
my $upper_toleranceRT = $RTs + $tolerance_RT;
my $lower_toleranceRT = $RTs - $tolerance_RT;
# my select statement to select the interference values
my $statements = qq{select distinct peptide.peptide_sequence,
peptide.hydrophobicity, precursor.precursor_m/z, precursor.precursor_charge,
product.product_m/z, product.product_type, product.product_number from
peptide join precursor on peptide.peptide_id = precursor.peptide_peptide_id
join product on peptide.peptide_id = product.peptide_peptide_id where
hydrophobicity >= '$lower_toleranceRT' and hydrophobicity <=
'$upper_toleranceRT' and precursor_m/z >= '$lower_tolerancepre' and
precursor_m/z <= '$upper_tolerancepre' and product_m/z >=
'$lower_tolerancepro' and product_m/z <= '$upper_tolerancepro' and
peptide_sequence != '$peptide_sequencess' and product_m/z != '$prod_m/z';};
my $sth4 = $dbh->prepare($statements) || die "Cannot
prepare statement:" . DBI->errstr;
$sth4->execute() || die "Cannot execute statement:" .
DBI->errstr;
# retrieve require values from database
while (my @response = $sth4->fetchrow_array()){
#my $protein_ac = $response[0];
my $peptide_sequence = $response[0];
my $RT = $response[1];
my $precursor_m/z = $response[2];
my $precursor_charge = $response[3];
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my $product_m/z = $response[4];
my $product_type = $response[5];
my $product_number = $response[6];
# insert interference values into interference tables these values represent
the transitions that interfere with MRMaid transitions
#
my $sth5 = $dbh->prepare("insert into interference (peptide_sequence,
hydrophobicity, precursor_m/z, precursor_charge, product_m/z, product_type,
product_number, transitions_transitions_id) values(?,?,?,?,?,?,?,?)");
$sth5->execute( $peptide_sequence, $RT, $precursor_m/z,
$precursor_charge, $product_m/z, $product_type, $product_number, $table_key);
}
}
}
exit;
A.2.3 Retrieve_interference.pl
#! /usr/bin/perl -w
use strict;
use DBI;
use DBD::mysql;
my @datax;
my @datay;
my $peptide_sequencess;
my $RTs;
my $prec_m/z;
my $prec_charge;
my $prod_m/z;
my $product_typ;
my $product_numbe;
my $Peptide;
my $temp_q1 = 1;
my $temp_q3 = 1;
my $upper_tolerancepre;
my $lower_tolerancepre;
my $upper_tolerancepro;
my $lower_tolerancepro;
my $upper_toleranceRT;
my $lower_toleranceRT ;
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my $outputfile = 'transitions_MRMInter_1_.7_2.csv';
open (OUTFILE, ">$outputfile");
# get the search terms to add to the select statement
print " please enter your precursor tolerance \n";
my $tolerance_precursor = <STDIN>;
print " please enter your product tolerance \n";
#my $tolerance_product = <STDIN>;
my $tolerance_product = <STDIN>;
print " please enter your hydrophobicity tolerance \n";
my $tolerance_RT = <STDIN>;
print "Please wait while your data is being processed \n";
my $ds = "DBI:mysql:MRMInter:localhost";
my $user = "root";
my $passwd = "Peptide5";
my $dbh = DBI->connect($ds,$user,$passwd) || die "Can't
Connect!";
my $statement = qq{select distinct transition.peptide_sequence,
transition.hydrophobicity, transition.precursor_m/z,
transition.precursor_charge, transition.product_m/z, transition.product_type,
transition.product_number from transition;};
my $sth = $dbh->prepare($statement) || die "Cannot prepare statement:"
. DBI->errstr;
$sth->execute() || die "Cannot execute statement:" . DBI->errstr;
# retrieve required values from database
while (my $response = $sth->fetchrow_arrayref()){
$peptide_sequencess = $response->[0];
$RTs = $response->[1];
$prec_m/z = $response->[2];
$prec_charge = $response->[3];
$prod_m/z = $response->[4];
$product_typ = $response->[5];
$product_numbe = $response->[6];
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#print OUTFILE "Theoretical transition:
$peptide_sequencess\t$RTs\t$prec_m/z\t$prec_charge\t$prod_m/z\t$product_typ\t
$product_numbe \n";
my $upper_tolerancepre = $prec_m/z + $tolerance_precursor;
my $lower_tolerancepre = $prec_m/z - $tolerance_precursor;
my $upper_tolerancepro = $prod_m/z + $tolerance_product;
my $lower_tolerancepro = $prod_m/z - $tolerance_product;
my $upper_toleranceRT = $RTs + $tolerance_RT;
my $lower_toleranceRT = $RTs - $tolerance_RT;
# my select statement to select the interference values
my $statements = qq{ select interference.peptide_sequence,
interference.product_type, interference.product_number,
count(interference.interference_id) as NumberOfInterferences from transition,
interference where transition.peptide_sequence = '$peptide_sequencess' and
transition.product_type = '$product_typ' and transition.product_number =
'$product_numbe' and interference.hydrophobicity >= '$lower_toleranceRT' and
interference.hydrophobicity <= '$upper_toleranceRT' and
interference.precursor_m/z >= '$lower_tolerancepre' and
interference.precursor_m/z <= '$upper_tolerancepre' and
interference.product_m/z >= '$lower_tolerancepro' and
interference.product_m/z <= '$upper_tolerancepro' and
transition_transition_id = transition_id ;};
my $sth2 = $dbh->prepare($statements) || die "Cannot prepare statement:" .
DBI->errstr;
$sth2->execute() || die "Cannot execute statement:" . DBI->errstr;
#print OUTFILE "Pep-sequence\thydrophobicity\tPrec-m/z\tPrec-charge\tProd-
m/z\tProd-type\tProd-number \n";
# retrieve require values from database
while (my $response = $sth2->fetchrow_arrayref()){
#my $protein_ac = $response[0];
my $peptide_sequence = $response->[0];
my $RT = $response->[1];
my $precursor_m/z = $response->[2];
my $count = $response->[3];
my $product_m/z = $response->[4];
my $product_type = $response->[5];
my $product_number = $response->[6];
print OUTFILE " $peptide_sequencess,$product_typ,$product_numbe,$count
\n";
print " $peptide_sequencess\t$product_typ\t$product_numbe\t$count \n";
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}
}
close (OUTFILE);
#close (FILE);
exit;
A.2.4 Retrieve_interference2.pl
#! /usr/bin/perl -w
# Author: Oshiobugie Dokpesi
# Date: February 2013
# File: retrieve_interference2.pl
# Code Description: Program retrieves the interferences for transitions from
the interference table in MRMinter
use strict;
use DBI;
use DBD::mysql;
my @datax;
my @datay;
my $peptide_sequencess;
my $RTs;
my $prec_m/z;
my $prec_charge;
my $prod_m/z;
my $product_typ;
my $product_numbe;
my $Peptide;
my $upper_tolerancepre;
my $lower_tolerancepre;
my $upper_tolerancepro;
my $lower_tolerancepro;
my $upper_toleranceRT;
my $lower_toleranceRT ;
my $tolerance_precursor = .0001;
my $tolerance_product = .0001;
my $tolerance_RT = .0001;
# Get the search terms to add to the select statement
# as the select query will not allow a tolerance of 0 due to a neccesity for
a range
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# in order to search default setting for zero is 0.0001.
print " please enter your precursor tolerance \n";
my $temp_tolerance_prec = <STDIN>;
if($temp_tolerance_prec > .0001) {
$tolerance_precursor = $temp_tolerance_prec;
}
print " please enter your product tolerance \n";
my $temp_tolerance_pro = <STDIN>;
if($temp_tolerance_pro > .0001) {
$tolerance_product = $temp_tolerance_pro;
}
print " please enter your hydrophobicity tolerance \n";
my $temp_tolerance_RT = <STDIN>;
if($temp_tolerance_RT > .0001) {
$tolerance_RT = $temp_tolerance_RT;
}
print "Please wait while your data is being processed \n";
# output file to store the interference data can aslo be in .csv format
my $outputfile = 'transitions_mrmaid.txt';
open (OUTFILE, ">$outputfile");
my $ds = "DBI:mysql:MRMInter:localhost";
my $user = "root";
my $passwd = "Peptide5";
my $dbh = DBI->connect($ds,$user,$passwd) || die "Can't Connect!";
# select statement to search through all the transitions in the database.
this can be modified to search for only a subset of transtions.
my $statement = qq{select distinct transition.peptide_sequence,
transition.hydrophobicity, transition.precursor_m/z,
transition.precursor_charge, transition.product_m/z, transition.product_type,
transition.product_number from transition where transition.peptide_sequence =
'EIGELYLPK' and transition.precursor_m/z >= '531.2' and
transition.precursor_m/z <= '5531.30' and transition.product_m/z >= '633.3'
and transition.product_m/z <= '633.40';};
my $sth2 = $dbh->prepare($statement) || die "Cannot prepare
statement:" . DBI->errstr;
$sth2->execute() || die "Cannot execute statement:" . DBI->errstr;
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# retrieve required values from database
while (my @response = $sth2->fetchrow_array()){
$peptide_sequencess = $response[0];
$RTs = $response[1];
$prec_m/z = $response[2];
$prec_charge = $response[3];
$prod_m/z = $response[4];
$product_typ = $response[5];
$product_numbe = $response[6];
print OUTFILE " Interference for peptide :
$peptide_sequencess\t$RTs\t$prec_mz\t$prec_charge\t$prod_mz\t$product_typ\t$p
roduct_numbe \n";
# using the tolerance values inputted by to produce upper range and lower
range of values a required by select statement
$upper_tolerancepre = $prec_m/z + $tolerance_precursor;
$lower_tolerancepre = $prec_m/z - $tolerance_precursor;
$upper_tolerancepro = $prod_m/z + $tolerance_product;
$lower_tolerancepro = $prod_m/z - $tolerance_product;
$upper_toleranceRT = $RTs + $tolerance_RT;
$lower_toleranceRT = $RTs - $tolerance_RT;
# my select statement to select the interference values
# my select statement to select the interference values
my $statements = qq{ select distinct transition.peptide_sequence,
interference.peptide_sequence, interference.hydrophobicity,
interference.precursor_m/z, interference.precursor_charge,
interference.product_m/z, interference.product_type,
interference.product_number from transition join interference where
transition.peptide_sequence = '$peptide_sequencess' and
transition.product_type = '$product_typ' and transition.product_number =
'$product_numbe' and interference.hydrophobicity >= '$lower_toleranceRT' and
interference.hydrophobicity <= '$upper_toleranceRT' and
interference.precursor_m/z >= '$lower_tolerancepre' and
interference.precursor_m/z <= '$upper_tolerancepre' and
interference.product_m/z >= '$lower_tolerancepro' and
interference.product_m/z <= '$upper_tolerancepro' and
transition_transition_id = transition_id ;};
my $sth2 = $dbh->prepare($statements) || die "Cannot prepare
statement:" . DBI->errstr;
$sth2->execute() || die "Cannot execute statement:" . DBI->errstr;
#print OUTFILE "Pep-sequence\thydrophobicity\tPrec-m/z\tPrec-charge\tProd-
m/z\tProd-type\tProd-number \n";
# retrieve require values from database
while (my @response = $sth2->fetchrow_array()){
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my $peptide_sequencess = $response[0];
my $peptide_sequences = $response[1];
my $RT = $response[2];
my $precursor_m/z = $response[3];
my $precursor_charge = $response[4];
my $product_m/z = $response[5];
my $product_type = $response[6];
my $product_number = $response[7];
print OUTFILE "
$peptide_sequences\t$RT\t$precursor_m/z\t$precursor_charge\t$product_m/z\t$pr
oduct_type\t$product_number\n";
}
}
close (OUTFILE);
#close (FILE);
exit;
